Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
August-2026 Volume 58 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2026 Volume 58 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review)

  • Authors:
    • Xinxin Zhang
    • Biao Zhang
  • View Affiliations / Copyright

    Affiliations: College of Physical Education, Hainan Normal University, Haikou, Hainan 571158, P.R. China, School of Physical Education, China West Normal University, Nanchong, Sichuan 637009, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 220
    |
    Published online on: June 15, 2026
       https://doi.org/10.3892/ijmm.2026.5891
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Exercise exerts broad and sustained effects on metabolic homeostasis and overall physiology. However, the circulating mediators connecting localized exercise responses to coordinated systemic adaptation remain poorly defined, particularly those involved in inter‑organ communication and long‑term metabolic remodeling. Extracellular vesicles (EVs) have gained significant attention as key mediators in this signaling process, owing to their ability to transport proteins, metabolites, and RNAs between donor and recipient cells. Exercise dynamically modulates EV release, abundance, and cargo composition, suggesting that EVs may act as key mediators of exercise‑induced multisystem adaptation. Notably, exercise may alter the epigenetically active cargo of EVs, regulating epigenetic responses in target organs and ultimately shaping systemic metabolic homeostasis. Given the potential importance of these mechanisms in the long‑term systemic effects of exercise, a comprehensive review of the current evidence is essential. In the present review EV‑mediated epigenetic signaling in exercise is investigated, focusing on how exercise reshapes EV biogenesis and cargo composition, how EV‑associated epigenetic factors regulate recipient‑cell function, and how these processes may contribute to sustained metabolic adaptation. This perspective aims to clarify the mechanistic basis of exercise benefits and to highlight EVs as potential targets for precision diagnostics and therapeutic strategies.

Introduction

Regular exercise is essential for maintaining systemic metabolic homeostasis and overall health, reducing disease susceptibility, and improving long-term health outcomes (1-5). Reflecting these wide-ranging and sustained benefits, the World Health Organization has identified the promotion of exercise at the population level as a global public health priority (6). Structured exercise and lifestyle interventions yield measurable clinical benefits, particularly in high-risk populations. Previous studies within the LIGHT trial framework suggest that digital health-supported programs are associated with reduced atherosclerotic cardiovascular disease risk estimates and improved peak VO2, underscoring the clinical significance of exercise-induced systemic adaptation (7,8). However, the molecular mechanisms underlying these adaptations remain inadequately defined, including the circulating mediators that coordinate inter-organ signaling and the downstream pathways that support durable metabolic reprogramming (9,10). Defining these signaling mechanisms is essential to mechanistically linking local tissue responses to coordinated systemic adaptations and durable metabolic benefits.

Exercise induces profound changes in the systemic landscape, characterized by the influx of exercise-responsive nucleic acids, proteins, and metabolites into the circulation (11,12). These exercise-induced signals provide a molecular basis for the coordinated multi-organ response to exercise and are increasingly recognized as key drivers of the transition from short-term physiological regulation to long-term metabolic adaptation (13-15). Numerous exercise-induced signals are intrinsically unstable and lack canonical secretion motifs, making them unlikely to mediate long-range effects through passive diffusion alone. Consequently, extracellular vesicles (EVs) have emerged as important candidates for the transmission of exercise-related signals (16-18). EVs are lipid bilayer-enclosed vesicles released by nucleated cells that can carry donor cell-derived bioactive cargo, including metabolites, proteins, and RNA, to recipient cells, mediating targeted intercellular and inter-organ communication (19-22). However, the terminology used in exercise-EV studies remains variable, partly because vesicles are classified according to different criteria, including biogenesis, size, cellular origin, and isolation or characterization strategy (23,24). Thus, labels such as exosomes, small EVs, and microvesicles may describe overlapping but not necessarily identical vesicle populations across studies, with exosomes generally referring to vesicles of endosomal origin, microvesicles to vesicles shed from the plasma membrane, and small EVs to size-defined vesicle fractions (25). To avoid overclassification, the present review uses EVs as the overarching term and retains subtype-specific terminology when supported by the original reports. Although accumulating evidence indicates that exercise markedly alters EV abundance and molecular features, the precise role of these changes in mediating exercise-related biological effects remains poorly understood (26,27).

Among the potential mechanisms, epigenetic regulation is particularly well-suited to explain the enduring effects of exercise adaptation as it allows environmental cues to drive stable yet reversible changes in gene expression (28-30). Epigenetic regulation encompasses DNA methylation, histone post-translational modifications, and non-coding RNA (ncRNA)-mediated regulatory processes, all of which modulate chromatin state and gene expression without altering the underlying DNA sequence itself (31). Crucially, EVs can deliver epigenetically relevant cargo, particularly ncRNAs, to recipient cells, thereby providing a means for epigenetic regulation across tissues (32). Although EV-mediated effects may extend beyond microRNAs (miRNAs or miRs) to other classes of ncRNAs, including long non-coding RNAs and circular RNAs, and downstream chromatin-related regulation, direct evidence for these mechanisms in the exercise setting remains limited. By contrast, the strongest and most consistent evidence to date centers on EV-associated miRNAs, which therefore constitute the primary mechanistic focus of the present review (33,34). Substantial evidence indicates that EVs regulate diverse physiological and pathological processes, including metabolic homeostasis and inflammatory responses, and influence disease progression through the delivery of ncRNAs (35). Exercise, in turn, dynamically modulates EV release and cargo composition, thereby reshaping EV-mediated epigenetic regulation (36-38).

EVs have attracted broad translational interest as minimally invasive biomarkers and potential delivery-based therapeutic platforms, owing to their stability in biofluids and their capacity to carry protected molecular cargo (39-41). In the exercise field, changes in EV abundance, surface-marker profiles, and miRNA cargo have been associated with acute exercise responses, fatigue-related physiological stress, metabolic health, and training responsiveness (42-44). Therapeutic translation remains less established, with current evidence largely derived from preclinical studies suggesting that exercise-induced EVs or exercise-regulated cargo can modulate inflammation, tissue repair, cardiometabolic remodeling, and organ protection (45). However, the mechanisms governing the selection, delivery, and tissue-specific coupling of exercise-responsive EV cargo to epigenetic remodeling and downstream metabolic adaptation remain poorly defined. A systematic synthesis of current evidence is therefore needed to clarify how EV-mediated epigenetic signaling links exercise to sustained, multisystem metabolic benefits.

EVs: An intrinsic carrier for molecular protection and directed delivery

In 1967, Peter Wolf described platelet-derived 'platelet dust' in plasma, marking one of the earliest reports of circulating EVs (46). Initially considered waste disposal by-products, these vesicles are now recognized as functional mediators of intercellular communication (11,47). To standardize terminology, the International Society for Extracellular Vesicles proposed in 2018 that 'extracellular vesicles' should be used as the generic term for particles naturally released from cells (48). EVs are nanoscale, lipid bilayer-enclosed vesicles that transfer lipids, nucleic acids, proteins, and other biomolecules to nearby or distant recipient cells, thereby mediating intercellular communication (49). This EV-mediated communication pathway is evolutionarily conserved across prokaryotes, plants, and eukaryotes, including yeast and fungi (50). Based on their biogenesis, EVs are broadly divided into exosomes and plasma membrane-derived vesicles (51). Exosomes, typically within the small EV size range (30-150 nm), originate from the endocytic pathway as intraluminal vesicles within multivesicular bodies (MVBs) and are released when MVBs fuse with the plasma membrane. They are often enriched in CD9, CD63, CD81, ALG-2-interacting protein X, heat shock protein (HSP)70, and tumor susceptibility 101 (52,53). By contrast, plasma membrane-derived vesicles bud directly from the cell surface and include microvesicles (MVs, typically 501,000 nm) and apoptotic vesicles (100-5,000 nm), the latter being generated during apoptosis (54). After release, EVs may enter circulating biofluids, distribute locally or systemically, and reach distant recipient cells, enabling communication across both proximal and remote sites (39). Some EVs rapidly degrade after release, directly releasing cytokines or growth factors, whereas most remain stable in biofluids and can travel to specific tissues or distant target cells (11). Upon reaching target cells, EVs interact through three primary mechanisms: Receptor binding at the cell surface, direct membrane fusion, or endocytic uptake (55). The uptake of EVs varies by cell type and is largely governed by their surface protein composition, especially integrins, tetraspanins, and lectins (51). Additionally, EV cargo loading is increasingly recognized as a selective process, not a purely passive one. It involves mechanisms such as endosomal sorting complex required for transport (ESCRT)-dependent and ESCRT-independent pathways, lipid microdomain-associated processes, and RNA-binding protein-mediated loading of regulatory RNAs (56,57). This selective packaging further contributes to the molecular composition and functional specificity of EVs, influencing which regulatory signals are delivered to recipient cells (58,59).

Taken together, EVs should not be viewed as passive released cellular debris, but as active biological carriers that protect bioactive molecules from degradation and enable their selective delivery to recipient cells, thereby supporting intercellular and inter-organ communication (Fig. 1).

Biogenesis, release, transport, and
uptake of EVs. EVs are generated through distinct biogenetic routes
and carry bioactive cargo, including proteins, nucleic acids, and
lipids. Exosomes are formed through the endosomal pathway:
Endocytosis generates early endosomal compartments, which mature
into MVBs containing intraluminal vesicles; fusion of MVBs with the
plasma membrane releases these vesicles as exosomes, typically
within the small EV size range. Microvesicles are produced by
direct outward budding of the plasma membrane, whereas apoptotic
bodies are released during apoptosis. After release, EVs can travel
through extracellular fluids or the circulation and deliver donor
cell-derived signals to recipient cells. EV uptake may occur
through receptor binding at the cell surface, direct membrane
fusion, or endocytic internalization, thereby enabling transfer of
molecular cargo and contributing to intercellular and inter-organ
communication. EVs, extracellular vesicles; MVBs, multivesicular
bodies.

Figure 1

Biogenesis, release, transport, and uptake of EVs. EVs are generated through distinct biogenetic routes and carry bioactive cargo, including proteins, nucleic acids, and lipids. Exosomes are formed through the endosomal pathway: Endocytosis generates early endosomal compartments, which mature into MVBs containing intraluminal vesicles; fusion of MVBs with the plasma membrane releases these vesicles as exosomes, typically within the small EV size range. Microvesicles are produced by direct outward budding of the plasma membrane, whereas apoptotic bodies are released during apoptosis. After release, EVs can travel through extracellular fluids or the circulation and deliver donor cell-derived signals to recipient cells. EV uptake may occur through receptor binding at the cell surface, direct membrane fusion, or endocytic internalization, thereby enabling transfer of molecular cargo and contributing to intercellular and inter-organ communication. EVs, extracellular vesicles; MVBs, multivesicular bodies.

Cellular origins of exercise-induced EVs

As a systemic physiological stimulus, exercise reshapes circulating EV profiles by altering both EV release and cargo composition (37,60). While skeletal muscle is widely recognized as a major source of exercise-induced EVs, current evidence suggests that circulating EVs also originate from a broader range of cell types, including endothelial cells, platelets, and leukocytes, in response to both acute or chronic exercise (61-64). Notably, despite the marked plasticity of circulating EV signals, EVs from distinct tissue origins often retain relatively stable source-associated features (65) (Table I). These origin-dependent characteristics largely determine their surface molecular identity, cargo profile, tissue tropism, and cellular uptake efficiency, thereby influencing downstream signaling, transcriptional programs, and metabolic reprogramming in recipient cells, and ultimately shaping their functional effects in target organs (66). Accordingly, a systematic understanding of how exercise regulates EVs derived from different cellular sources is essential not only for elucidating the systemic adaptations to physical activity, but also for defining the physiological functions of EVs and their potential diagnostic and therapeutic value.

Table I

Major cellular sources and defining features of exercise-related EVs.

Table I

Major cellular sources and defining features of exercise-related EVs.

EV originSpecific cargoExercise responseMajor biological functionSurface markers
Skeletal musclemiR-1, miR-133a/b, miR-206, miR-486, miR-499Dynamically remodeled by exercise mode, intensity, duration, and training statusMediate local myofiber communication and long-range inter-organ signaling; contribute to myogenesis, regeneration, metabolic adaptation, insulin sensitivity, and systemic homeostasisSGCA, CD81
PlateletsPlatelet activation-related proteins, membrane lipids, procoagulant and signaling moleculesRapidly increased after acute high-intensity exercise; transient and intensity-dependentReflect platelet activation, acute physiological stress, and vascular-hemostatic responses; may participate in coagulation, inflammation, and post-exercise vascular adaptationCD41, CD42, CD31
Endothelial cellsEndothelial activation- or injury-related proteins, adhesion molecules, and regulatory nucleic acidsVariable responses depending on exercise protocol, fitness level, and study methodReflect endothelial activation, vascular stress, and vascular fitness; may serve as indicators of endothelial adaptation to exerciseCD144, CD62E, CD105, CD146
Regulatory T cellsmiR-150-5p, miR-146a-5p, miR-21-5pAltered with exercise-induced immune activationInvolved in immune cell communication, inflammatory regulation, and exercise-associated immune adaptationCD45, CD11b, CD14, CD16

[i] EV, extracellular vesicle; miR, microRNA; SGCA, α-sarcoglycan; CD, cluster of differentiation.

Skeletal muscle-derived EVs

Skeletal muscle, comprising 35-40% of body mass, functions as both a primary motor effector and a critical endocrine organ. Beyond myokine secretion, emerging evidence indicates that skeletal muscle also releases bioactive EVs, mediating complex intercellular and inter-organ communication (67). Guescini et al (68) were the first to show that myoblasts release exosome-like vesicles (50-80 nm) enriched in signaling-related proteins and mitochondrial DNA, suggesting their role in transferring genetic and metabolic information between muscle cells and potentially across organs. This view was further supported by the detection of fluorescently labeled EVs in distant, including contralateral, muscles after intramuscular injection (69). In vitro and animal studies further indicate that multiple skeletal muscle cell types, including myoblasts, myotubes, and satellite cells, can release exosomes enriched in muscle-specific miRNAs (myomiRs) such as miR-1, miR-133a/b, miR-206, and miR-486 (70,71). These myomiRs, which are highly enriched in muscle tissue, play important roles in myogenesis, differentiation, regeneration, and stress responses (61,72).

Exercise can markedly alter both the abundance and molecular cargo of circulating exosomes, in a manner that depends on exercise modality, intensity, and host-related factors (61). Different forms of exercise, including uphill running, downhill running, endurance training, and resistance training, induce distinct changes in exosomal miRNA expression patterns, with dynamic fluctuations in molecules such as miR-1, miR-133a, miR-499, and miR-486 (73). Among these, miR-486 can target PTEN and thereby enhance insulin-like growth factor-1/protein kinase B/mechanistic target of rapamycin (IGF-1/AKT/mTOR) signaling, suggesting that exercise-induced exosomal miRNAs may contribute to protein synthesis, glucose homeostasis, and improved insulin sensitivity (74). On the basis of these findings, skeletal muscle is now considered a major source of circulating exosomes.

Functionally, muscle-derived EVs help maintain local tissue homeostasis by promoting myoblast differentiation, supporting neuromuscular junction integrity, and protecting motor neurons (75). They can also reach distant metabolic organs, where they influence signaling pathways involved in insulin responsiveness, glucose handling, lipid metabolism, and systemic metabolic homeostasis (76-79). Altered muscle exosomal cargo has been linked to both pathological and adaptive responses in neuromuscular and metabolic diseases, highlighting the potential of muscle-derived EVs as biomarkers and therapeutic targets (80-84).

Platelet-derived EVs

A substantial proportion of human studies investigating the effects of acute exercise on circulating EVs have focused on larger vesicle populations, particularly MVs exceeding 500 nm in diameter (27). Among these, platelet-derived microvesicles (PMVs) represent the most abundant MV subset in circulation and have attracted significant attention due to their robust responsiveness to exercise (85-87). Across a range of high-intensity endurance modalities, including maximal incremental exercise testing, heavy-intensity cycling, sustained aerobic exercise near 70-85% of maximal capacity, and high-intensity interval protocols, PMVs consistently exhibit marked increases during or shortly after exercise (88-91). Notably, these changes appear to be intensity dependent, as moderate-intensity exercise does not elicit comparable elevations (92). Moreover, the PMV surge is transient, with concentrations peaking during exercise or early recovery and returning toward baseline within 30-120 min (85,86,92). Together, these findings highlight PMVs as dynamically regulated vesicles that may reflect acute physiological stress and vascular activation during strenuous exercise.

Endothelial cell-derived EVs

Compared with PMVs, the exercise-induced behavior of endothelial-derived microvesicles (EMVs) is less consistent. While several studies have demonstrated post-exercise elevations in EMVs (91,93), others have reported no change or even reductions, both in healthy and metabolically compromised individuals (85,89,94). These discrepancies likely reflect methodological variability in EV isolation and characterization, as well as differences in exercise intensity, modality, and participant characteristics. Notably, emerging evidence suggests that training status may critically shape EMV dynamics. In highly trained endurance athletes, distinct heavy-intensity exercise formats, including prolonged submaximal workloads, repeated high-intensity intervals, and maximal sprinting, were uniformly associated with reductions in circulating EMVs, potentially reflecting enhanced vascular function and accelerated vesicle clearance in trained individuals (95,96). These observations underscore that EMV responses are not uniform and may integrate information about both exercise stimulus and vascular fitness.

Regulatory T cell-derived EVs (Treg-EV)

Treg-EVs primarily carry a range of immunosuppressive molecules and miRNAs that contribute to the maintenance of immune tolerance and the suppression of inflammatory responses (74). They are enriched in molecules such as CD39, CD73, cytotoxic T-lymphocyte-associated protein 4, IL-35 subunits, IL-10, and TGF-β, as well as regulatory miRNAs including miR-150-5p, miR-146a-5p, and miR-21-5p (76,97-99). Among these, miR-146a-5p has been shown to suppress CD4+ T-cell proliferation, further supporting the immunoregulatory function of Treg-EVs (100). During exercise, Treg-EVs may exert immunomodulatory effects through these molecular cargos, attenuating inflammatory responses and fostering an anti-inflammatory milieu, particularly in chronic metabolic disorders such as diabetes and obesity, as well as during recovery from exercise-induced muscle injury (100). Notably, Treg cells may act in concert with skeletal muscle-derived EVs to coordinate post-exercise immune adaptation and tissue repair (62,101). For example, muscle-derived EVs may enhance Treg activation and immunosuppressive function through miRNAs such as miR-206, amplifying anti-inflammatory signals via EV-mediated communication (102). Simultaneously, Treg-EVs may suppress excessive immune-cell responses and reinforce immune tolerance through the delivery of miR-146a-5p (103). In this cooperative framework, EVs, through their carried cargo, may serve dual roles in regulating immune responses and promoting both metabolic health and tissue repair.

Exercise-driven changes in EV composition and function

Exercise, including acute and chronic exercise, refers to voluntary movements produced by skeletal muscles that elevate energy expenditure (104,105). In response to the increased physiological demands of exercise, the body engages coordinated adaptations across metabolic, cardiovascular, and immune systems, collectively underpinning the broad and sustained health benefits of regular physical activity (106-109). In 2015, Frühbeis et al (110) were the first to systematically document the rapid changes in circulating EVs following acute exercise, identifying EVs as potential mediators of exercise-induced inter-organ communication. By transporting proteins, lipids, and regulatory RNAs through the circulation, EVs can relay local signals generated by contracting skeletal muscle to distant tissues, including the vasculature, liver, adipose tissue, and immune system, thereby linking muscle activity to systemic adaptation (111-113). Recent studies indicate that EV responses vary substantially across different exercise modalities. Acute vs. chronic exercise, along with variations in intensity and duration, each reshape EV abundance, cellular origin, and cargo composition in distinct ways (114-116). For example, short bouts of cycling are associated with increased exosomal miR-1, whereas longer-duration exercise induces a broader myomiR response, including miR-1, miR-133a/b, miR-206, miR-208a, and miR-499 (73,117,118). The present review synthesizes recent evidence on the dynamic behavior of EVs across different forms of exercise, particularly endurance and resistance training, offering a clearer framework for understanding the mechanisms of exercise adaptation (Table II).

Table II

Exercise-induced alterations in circulating EVs.

Table II

Exercise-induced alterations in circulating EVs.

Exercise protocolBio-fluidTime of collectionIsolation methodVerification methodTerminologyExercise effectYear(Refs.)
Acute exerciseIncremental cycling or treadmill running to exhaustion in healthy adultsPlasmaPre-exercise, immediately post-exercise, and 90 min post-exerciseDifferential centrifugation, including 10,000 × g pre-clearing, filtration, and 100,000 × g ultracentrifugationNTA and WBSmall EVs/exosome-like vesiclesSmall EVs increased immediately after cycling and declined by 90 min; the running response was more moderate but appeared more sustained2015(110)
Incremental cycling test to exhaustion in healthy male athletesEDTA plasmaPre-exercise, during exercise (RQ=0.9), and immediately post-exerciseEV Array on total plasma; SEC; CD9/CD63/CD81 immunobead isolationEV Array, NTA, WB, and multiplex flow cytometryEVsEV levels increased progressively during exercise and peaked at maximal load; ExerVs showed mixed leukocyte-, platelet-, and endothelial-associated features2019(132)
Single 40-min treadmill bout (low-, moderate-, or high-intensity) in ratsSerumImmediately after the exercise boutExoQuick-based precipitation from platelet-depleted serumTEM/immun o-EM, TRPS, and WBEVsEV concentration increased, whereas size was not significantly changed; CD63-positive vesicles increased and small-RNA cargo was altered2018(131)
Moderate-intensity treadmill exercise (60% VO2max) in obese and normal-weight adultsPlasmaPre-exercise, immediately post-exercise, 3 h, and 24 hPlasma EV isolation/purification (supplementary protocol), followed by NTA and flow-based phenotypingNTA and flow cytometryTotal EVs, exosomes, and microvesiclesTotal circulating EVs decreased overall (mainly microvesicle-range EVs); CD61+ EVs decreased,whereas SGCA+ EVs increased; responses were sex- and BMI-dependent2020(133)
60-min cycling in healthy men (30 min at 55%, 20 min at 70%, then ~10 min at 80% VO2max to exhaustion), with 4-h recoveryPlasmaBaseline, end of exercise, and 4 h recoveryRapid plasma preparation followed by high-speed centrifugation to obtain a 20,000 × g EV fraction for proteomicsNTA, cryo-EM, and nano-UHPLC-MS/MS proteomicsEVs, exosomes, and small vesiclesExercise increased systemic release of EV-associated proteins and enriched exosome/small-vesicle signatures; exercise-liberate2018(26)
Clinical exercise stress testing in human subjectsEDTA plasmaAt rest, peak exercise, and 15 min after exercisePlasma preparation by sequential centrifugation; direct particle analysis by nano-flow cytometryNano-flow cytometryEVs/plasma EVsAcute exercise induced a rapid increase in circulating plasma EVs2017(44)
Chronic exercise3-week swimming in miceSerumAfter completion of the training periodPlasma EV isolation followed by size and phenotyping analysesNano-flow cytometryEVs/serum EVsSerum EVs were increased (~1.85-fold) after training2017(44)
Daily moderate treadmill exercise (20 min/day for 2 weeks) in ratsSerum1 h and 18 h after the last exercise sessionPrecipitation-based isolation (miRCURY Exosome Isolation Kit)Marker assays and biochemical profilingEVs/exosomesExercise produced delayed changes in circulating EV profile, with alterations more evident 18 h after the last session2018(146)
4-week swim training in rats/trained human volunteersPlasma24 h after the last training sessionDifferential ultracentrifugation; ExoQuick also usedExosome characterizati on plus functional assaysCirculating exosomes/plasma exosomesTotal circulating exosome level did not change significantly 24 h post-exercise, but cargo composition/function was altered2019(45)
4-week treadmill training (low vs. moderate intensity; 60 min/day, 5 days/week) in micePlasma24 h after the last bout of exerciseMicrobead-based sorting of circulating EPC-derived exosomesNTA, WB qPCR, Exosomes/EPC-derived exosomesExercise increased circulating EPC-derived exosome release in an intensity-dependent manner2018(150)

[i] EVs, extracellular vesicles; EDTA, ethylenediaminetetraacetic acid; NTA, nanoparticle tracking analysis; WB, western blotting; TEM, transmission electron microscopy; TRPS, tunable resistive pulse sensing; SEC, size-exclusion chromatography; RQ, respiratory quotient; SGCA, α-sarcoglycan; EPC, endothelial progenitor cell; qPCR, quantitative polymerase chain reaction.

Acute exercise-induced changes in EVs

Acute exercise refers to a single bout of short-duration physical activity, typically lasting from several minutes to a few hours (119,120). Unlike the chronic adaptations associated with long-term training, acute exercise primarily represents a rapid physiological response to transient physical stress that can quickly reconfigure multisystem homeostasis and confer immediate health benefits (121-123). Even a single acute exercise bout can acutely improve systemic metabolic status, enhance insulin sensitivity, and promote energy utilization in major metabolic organs such as skeletal muscle and the liver (124-126). In addition, acute exercise exerts both anti-inflammatory and immune-activating effects, providing a brief but efficient form of endogenous protection through improved endothelial function and redistribution of immune cell populations (127,128).

A substantial body of human evidence consistently shows that acute exercise is a potent stimulus for the transient elevation of circulating EVs (129). Early exploratory research used graded cycling or treadmill tests to impose acute physiological stress in healthy, physically active men and assessed plasma small EV kinetics after isolation by differential centrifugation and ultracentrifugation (100,000 × g). This research showed that acute exercise rapidly increases circulating small EV levels: In cycling protocols, particle concentrations rose by approximately 2- to 3-fold and exosomal marker proteins by ~5-fold, peaking immediately after exercise and returning to baseline within 90 min of recovery (110). Notably, EV release occurred before the anaerobic threshold and exhibited rapid release-and-clearance kinetics, supporting a role for EVs as immediate physiological signaling mediators rather than passive by-products of tissue damage (110).

A parallel study of healthy men highlights a distinct kinetic divergence between exercise paradigms: While cycling triggered a sharp, transient peak in EV abundance, an incremental treadmill test resulted in a more moderate (~1.5-fold) elevation in circulating small EVs, which remained elevated for 90 min and required 6 h to return to baseline (130). Animal models further corroborate these dynamics. In Wistar rats, acute treadmill running significantly enhanced serum EV concentrations and protein content without a concomitant surge in total small-RNA yield (131). These findings suggest that the exercise-induced signal resides not in the sheer abundance of RNA, but in the selective remodeling of the molecular cargo. Deep sequencing has identified 12 differentially expressed miRNAs following exercise, whose targets predominantly converge on the MAPK signaling pathway (131). These data indicate that acute aerobic exercise rapidly reshapes both the physical abundance and the molecular signature of circulating EVs, positioning them as precise mediators of immediate inter-organ signaling.

The cellular origins of acute exercise-induced EVs are highly context-dependent. In healthy men performing a fasting, graded cycling-to-exhaustion test, EV-associated signals progressively increased during exercise peaking at exhaustion. Under these acute exhaustive conditions, exercise-induced EVs predominantly originated from lymphocytes, monocytes, endothelial cells, and platelets, with no significant contribution from skeletal muscle-derived EVs (132). By contrast, research using moderate-intensity exercise revealed a different pattern. In sex-stratified cohorts of both obese and normal-weight individuals, acute treadmill exercise (~60% VO2max) rapidly reshaped the circulating EV landscape. Skeletal muscle-derived α-sarcoglycan (SGCA)+ EVs increased immediately after exercise, whereas platelet-derived CD61+ EVs declined during recovery, particularly at 24 h (133). These responses also varied by sex and metabolic status: Women showed higher MV but lower exosome levels, and normal-weight individuals exhibited a stronger MV response than obese participants (133). Consistent with this, additional research has demonstrated marked sex differences in exercise-induced microparticle responses, with men showing post-exercise increases in CD62E+ endothelial microparticles, while women showed a more pronounced rise in CD34+ microparticles (91). Together, these findings indicate that the source composition of exercise-induced EVs is shaped not only by exercise intensity and modality, but also by sex and metabolic state.

Beyond changes in abundance and cellular origin, acute exercise also reshapes EV function. In healthy men undergoing incremental cycling, Whitham et al (26) showed that acute exercise induces a marked but transient remodeling of the circulating EV proteome, with 322 proteins significantly altered immediately after exercise and most changes largely resolving within 4 h. Upregulated proteins were enriched in pathways related to vesicle biogenesis, membrane trafficking, adhesion, cytoskeletal remodeling, and signal transduction, highlighting a rapid activation of EV-associated signaling machinery (26). Notably, exercise-derived EVs showed greater hepatic accumulation than resting EVs and were capable of transferring protein cargo to hepatocytes, supporting their role as active mediators linking contracting tissues to metabolic organs rather than passive by-products of exercise (26). The functional relevance of exercise-induced EVs extends to vascular biology. In healthy men, vigorous acute exercise rapidly increased circulating endothelial-derived microparticles, and phenotypic analysis indicated that these vesicles primarily reflected endothelial activation rather than overt endothelial apoptosis (94). This suggests that acute exercise-induced EV release is more closely associated with adaptive endothelial stress signaling than with widespread vascular injury. Accordingly, circulating EVs may serve not only as sensitive indicators of exercise stress, but also as early effectors of vascular repair, endothelial regulation, and exercise-induced cardiovascular protection.

Although still limited, current in vivo evidence strongly supports a functional role for EVs in mediating the cross-organ protective effects of acute physical activity. Acute exercise rapidly increases circulating EVs, many of which are predominantly derived from activated platelets and endothelial cells, while simultaneously remodeling their cargo, including proteins, miRNAs, and metabolites. By carrying these exercise-responsive signals through the circulation, EVs may coordinate multiorgan metabolic adaptation and functional integration through epigenetic regulation and the modulation of key signaling pathways.

Chronic exercise-induced changes in EVs

Chronic exercise refers to regular physical activity performed over an extended period (134,135). Unlike the transient physiological stress triggered by a single bout of acute exercise, chronic exercise is characterized by repeated exercise stimuli that drive durable functional adaptation and structural remodeling, resulting in broad, long-lasting, and systemic health benefits (136-138). Long-term exercise training substantially lowers the risk of multiple non-communicable diseases, including metabolic disorders (such as obesity and type 2 diabetes), cardiovascular disease, cancer, and neurodegenerative conditions (134,136,139,140). Through long-term physiological regulation, chronic exercise reshapes systemic metabolic homeostasis, supports more efficient energy utilization and insulin sensitivity, delays biological aging, and ultimately extends healthspan (141-143). In addition, by improving the overall immune microenvironment, chronic exercise enhances long-term host defense against pathogen exposure (144,145).

At the molecular level, in contrast to the rapid post-exercise rise in circulating small EVs observed after acute exercise, the effects of chronic exercise training on circulating EVs appear to be more consistent with a delayed, homeostatic form of remodeling (27). In a study of Wistar rats across different age groups, Bertoldi et al (146) applied a 2-week moderate-intensity treadmill training protocol (20 min/day, ~60% VO2max) and collected blood at 1 h and 18 h after the final session. Training-related effects were observed mainly at the 18-h time point, suggesting that regular aerobic exercise may promote exosome release or increase circulating exosome-associated components in a delayed manner (146). In aged animals, elevated EV-associated acetylcholinesterase activity was reduced after training, indicating that chronic exercise may also partially correct aging-associated EV abnormalities. Notably, this study also identified time-of-day differences in CD63 measurements (afternoon vs. the following morning), underscoring the importance of strict control of sampling time and circadian factors in studies of chronic exercise and EV biology (146). Overall, these findings suggest that chronic exercise contributes to sustained systemic protection, at least in part, by remodeling the quantitative profile of circulating EVs.

Further evidence for the organ-protective effects of exercise-derived EVs comes from chronic training models. In a 3-week swimming-trained mouse model, Bei et al (44) showed that chronic endurance exercise increased circulating EV abundance and, more importantly, that the transfer of EVs from exercised mice reduced ischemic myocardial injury, suppressed cardiomyocyte apoptosis, and improved cardiac function in recipient animals (44). Similar protective effects were observed in vitro, where exercise-derived EVs enhanced cardiomyocyte survival and attenuated apoptotic signaling. These actions were closely linked to activation of ERK1/2-HSP27 signaling, supporting the view that exercise-induced EVs are not merely by-products of training, but active effectors of remote organ protection and post-stress tissue recovery. When sampling time is carefully controlled, however, the effects of chronic training on circulating exosome levels appear more nuanced. In trained young male rowers and swim-trained rats, plasma exosome size and concentration were unchanged 24 h after the final exercise bout, yet exosomes from trained subjects displayed enhanced cardioprotective activity (137). Specifically, these exosomes were more readily taken up by cardiomyocytes, reduced hypoxia/reoxygenation injury in vitro, and attenuated ischemia-reperfusion damage in vivo. This functional remodeling was linked to enrichment of miR-342-5p, which inhibits caspase-9/c-Jun N-terminal kinase 2(Caspase9/JNK2)-dependent apoptosis and enhances AKT-mediated survival signaling (137). More broadly, chronic exercise appears to promote long-term adaptation and disease protection by selectively remodeling the cargo of EVs from different tissues. In db/db mice, 8 weeks of treadmill training increased exosome release and elevated miR-455 and miR-29b, thereby attenuating diabetic myocardial remodeling through suppression of matrix metalloproteinase 9 (MMP9) (147). A recent human study further extends these observations to metabolic disease settings. In individuals with insulin resistance or type 2 diabetes, 12 weeks of high-intensity interval training followed by detraining was associated with partially sustained improvements in energy metabolism and hepatic insulin sensitivity, raising the possibility that small EV remodeling contributes to the persistence of some exercise-induced metabolic benefits (148). Similarly, a study in sedentary adults with obesity showed that endurance training significantly remodeled the circulating EV proteome and reduced systemic inflammation, even without marked changes in EV abundance (149). Together, these findings suggest that, under metabolically compromised conditions, exercise may reprogram EV function not only by altering vesicle levels, but also by reshaping EV cargo and signaling properties (149). Chronic exercise has also been shown to enhance vascular repair through endothelial progenitor cell (EPC)-derived EVs: 4 weeks of treadmill training increased circulating EPCs, boosted EPC exosome release and miR-126 content, and promoted adaptive vascular remodeling via the sprouty-related EVH1 domain-containing 1/vasular endothelial growth factor axis (150). In addition to RNA cargo, chronic exercise may also remodel EV-associated proteins, as suggested by increased skeletal muscle HSP60 after endurance training, raising the possibility that EV-associated protein signals contribute to systemic adaptation (151).

Taken together, current evidence supports a central role for EVs in mediating the long-term benefits of chronic exercise. Rather than simply increasing circulating EV levels, chronic exercise appears to induce a more stable functional reprogramming of EV cargo, enabling sustained miRNA- and protein-mediated signaling that may reinforce epigenetic remodeling, metabolic adaptation, and systemic homeostasis.

Exercise-induced EVs as mediators of epigenetic remodeling

Exercise-induced changes in EVs are likely to be functionally important because they may reshape the regulatory information delivered to recipient cells (152). By altering EV abundance, subtype distribution, and cargo composition in a context-dependent manner, exercise can modify the intercellular transfer of miRNAs, proteins, metabolites, and other bioactive molecules (153). Once delivered to recipient cells, these cargos can influence signaling networks and gene programs involved in metabolism, inflammation, stress adaptation, and tissue repair (154-156). Among them, ncRNAs are especially notable, as they provide a plausible route through which exercise-responsive EVs may participate in epigenetic regulation across tissues (157). EV remodeling may therefore represent a mechanistic link between transient exercise stimuli and longer-term molecular adaptation (158). This perspective provides an important framework for considering how exercise-induced EV signaling intersects with epigenetic remodeling.

Exercise-induced epigenetic remodeling

Epigenetics refers to the dynamic regulation of gene expression through a series of plastic and reversible mechanisms that occur without altering the underlying DNA sequence (159-161). First introduced by Waddington in 1942, the concept describes how organisms establish structurally dynamic regulatory states within chromatin to precisely control transcriptional programs and adapt to environmental cues (162-164). Broadly, epigenetic regulation encompasses DNA methylation, histone post-translational modifications, chromatin remodeling, and regulation mediated by ncRNAs (165-167). These mechanisms allow external stimuli to be translated into changes in gene expression, thereby influencing metabolic homeostasis, inflammatory responses, stress adaptation, tissue repair, and disease progression (168-170). Notably, exercise can induce epigenetic reprogramming through changes in energy metabolism, redox status, and fluctuations in key metabolites such as acetyl-CoA, NAD+, and lactate (171-173). These effects include modulation of DNA methylation at metabolism-related genes, shifts in histone acetylation and methylation, and remodeling of miRNA expression profiles, ultimately influencing mitochondrial biogenesis, fatty acid oxidation, glucose metabolism, insulin sensitivity, and inflammatory-oxidative stress responses (174-178). Because these epigenetic responses are dynamic, context-dependent, and partially persistent after training, they provide a plausible mechanistic basis for the sustained metabolic and systemic benefits of exercise (5,179-181).

Within this framework, ncRNAs, especially miRNAs, have emerged as key regulatory effectors (182-184). Exercise markedly alters miRNA profiles in both tissues and in the circulation, with these changes being increasingly linked to pathways governing metabolism, inflammation, angiogenesis, mitochondrial function, and tissue repair (185-188). Notably, a subset of miRNAs can be selectively packaged into EVs and transferred between tissues (37,189,190). This suggests that exercise-induced EV-associated miRNAs may serve as mobile epigenetic signals that connect local muscle activity to systemic adaptive remodeling (38,191,192).

Exercise-derived EVs as epigenetic messengers

Given the central roles of EVs and epigenetic regulation in exercise adaptation and metabolic health, increasing attention has recently focused on whether exercise-induced EV remodeling may function as a cross-tissue information carrier, mediating ncRNA-driven epigenetic regulation and thereby contributing to systemic metabolic benefits (193). Although this field remains in its early stages, available evidence increasingly suggests that physical activity can alter the abundance, subtype composition, and cargo profile of circulating EVs, particularly their ncRNA content, including miRNAs, and may thereby influence transcriptional programs, signaling states, and long-term adaptive remodeling in target tissues (61). To systematically evaluate the evidence on exercise-induced EV remodeling and its potential epigenetic relevance, a PubMed search was conducted using the following terms: ('exercise'[Title/Abstract] OR 'physical activity'[Title/Abstract]) AND ('extracellular vesicles'[Title/Abstract] OR 'exosomes'[Title/Abstract] OR 'EVs'[Title/Abstract]). After merging results, removing duplicates, and applying stringent screening criteria, studies were included in which exercise was the primary intervention and EVs were evaluated as mediators, biomarkers, or functional effectors, with particular emphasis on studies explicitly examining EV cargo remodeling and its roles in epigenetic regulation, inter-organ communication, or downstream transcriptional/metabolic reprogramming (Table III).

Table III

Epigenetic effects associated with exercise-induced EVs.

Table III

Epigenetic effects associated with exercise-induced EVs.

Exercise protocolEV source/sampleEpigenetic change (cargo remodeling)Epigenetic effectsYear(Refs.)
Single flywheel-based iso-inertial resistance session in trained menCirculating EVs from bloodAcute exercise increased EV-encapsulated miR-206 and miR-146aSuggests rapid EV-mediated transfer of regulatory miRNAs during early post-exercise adaptation, potentially coupling inflammation to muscle remodeling2019(194)
Acute exercise/fitness-related comparison in young menPlasma EVs, including SGCA+ muscle-enriched EVsMuscle-derived EVs were enriched in miR-206; EV miR-133b and miR-181a-5p increased after acute exerciseSupports skeletal muscle as a source of circulating EV-miRNAs that may contribute to muscle remodeling, homeostasis, and inter-organ communication2015(68)
Two consecutive bouts of muscle-damaging exercise (plyometrics + downhill running)Plasma EVsNo major change in EV number or canonical myomiRs; EV miR-31 decreased at 24 hIndicates selective EV cargo repackaging after muscle-damaging exercise, with miR-31 emerging as a potential regulator of early recovery/remodeling2018(195)
Acute uphill vs. downhill running in ratsPlasma, exosomal, and exosome-free fractionsAfter downhill exercise, exosomal miR-1, miR-133a, miR-133b, miR-206, miR-208a, miR-499 increased during early recovery; uphill exercise produced little exosomal changeSuggests exercise mode-specific EV-miRNA remodeling, with eccentric loading preferentially engaging exosomal miRNA signaling during recovery2019(73)
Acute 40-min cycling in sedentary vs. endurance-trained older men; comparison of chronic training statusPlasma exosomesBaseline exomiR profiles differed by training status; acute exercise-induced distinct exomiR signatures in trained vs. sedentary menSuggests regular training reshapes EV-mediated epigenetic signaling and may counteract age-related anabolic resistance2020(196)
Long-term swim training in rats; trained vs. untrained human volunteersCirculating plasma exosomesLong-term exercise enriched exosomal miR-342-5p without changing total exosome abundance at 24 hExercise-derived exosomes conveyed sustained cardioprotection, reduced cardiomyocyte apoptosis, and protected against myocardial ischemia/reperfusion injury2019(45)
Treadmill exercise in db/db diabetic miceSerum and heart-associated exosomes ('cardiosomes')Exercise enhanced exosomal release and increased miR-29b and miR-455Reduced MMP9 activity, attenuated extracellular matrix remodeling, and potentially limited fibrosis and diabetic cardiac injury2015(147)

[i] EVs, extracellular vesicles; miR or miRNA, microRNA; SGCA, α-sarcoglycan; exomiR, exosomal microRNA; MMP9, matrix metalloproteinase 9; db/db, leptin receptor-deficient diabetic mice.

The earliest evidence for exercise-induced EV-miRNA remodeling came from studies showing that exercise alters not only the abundance of circulating EVs, but also the loading of specific miRNAs into these vesicles. Guescini et al (68) first identified a circulating EV subpopulation with myogenic features (SGCA+/CD81+) enriched in muscle-related miRNAs such as miR-206. They also showed that several EV-associated miRNAs were positively correlated with VO2max at rest. After acute aerobic exercise, EV-miR-181a-5p levels significantly increased, while EV-miR-133b showed an upward trend, supporting the notion that exercise-related changes in circulating miRNAs may arise, at least in part, from active EV-mediated secretion and cargo loading rather than passive leakage from damaged tissues (68). Subsequent research reinforced this concept by showing that exercise modality influences EV-miRNA sorting. In rats, eccentric-biased downhill running, but not concentric-biased uphill running, increased multiple myomiRs in exosome-enriched fractions during early recovery. This suggests that higher mechanical strain more readily drives myomiRs into EV-associated transport pathways (73). This pattern is consistent with observations from high mechanical-load resistance exercise. After a single bout of flywheel-based inertial squats, circulating EV levels increased and EV-encapsulated miR-206 and miR-146a were selectively elevated, whereas several other miRNAs remained unchanged (194). These changes occurred alongside markers of muscle inflammation, immune activation, and recovery signaling, suggesting that EV-mediated ncRNA output may be integrated into a broader program of post-exercise stress, inflammation, and tissue remodeling. Notably, some research indicates that exercise-induced EV remodeling may be driven more by selective cargo changes than by changes in vesicle number. In untrained men subjected to a muscle-damaging exercise protocol, EV size and particle number remained unchanged, whereas EV cargo was selectively remodeled, with a significant decline in miR-31 at 24 h. Together with concurrent increases in creatine kinase and delayed-onset muscle soreness, this finding suggests that EV-mediated miRNA remodeling may contribute to post-exercise repair, potentially through satellite cell-related pathways (195). In chronic training, EV-miRNA responses appear further shaped by training status. In older men, long-term endurance training produced a stable resting exosomal miRNA signature distinct from that of sedentary controls (196). Following an acute bout of cycling, both trained and sedentary individuals exhibited exomiR remodeling, but the composition and temporal dynamics of these changes differed markedly between groups. Pathway analysis suggested that numerous exercise-responsive exosomal miRNAs target key nodes within the IGF-1/AKT/mTOR/Forkhead box O axis, with trained individuals showing a profile more consistent with IGF-1 pathway activation (196). These findings indicate that long-term training can reprogram the EV-miRNA response to acute exercise, supporting the view that EV-miRNAs may function both as molecular fingerprints of training status and as mediators of adaptive signaling.

Previous research has advanced from descriptive profiling to functional and mechanistic validation of exercise-induced EV-miRNA remodeling. In a diabetic heart model, regular exercise increased cardiac-associated EV release and remodeled their miRNA cargo, notably upregulating miR-29b and miR-455. Mechanistically, these exercise-induced EV-miRNAs, particularly miR-455, were linked to reduced MMP9 expression and activity, thereby attenuating extracellular matrix remodeling, fibrosis, and myocardial dysfunction (146). In parallel animal and human studies, Hou et al (45) showed that chronic exercise did not necessarily increase circulating exosome abundance 24 h after training, but substantially altered exosomal miRNA composition and function. They identified miR-342-5p as a key exercise-induced exosomal miRNA that protects against ischemia-reperfusion injury by suppressing apoptosis-related targets, including Caspase9, Jnk2, and Ppm1f, while enhancing AKT-dependent survival signaling. Notably, laminar shear stress also increased miR-342-5p expression in endothelial cells and their exosomes, suggesting that exercise-induced hemodynamic signals may contribute to systemic protection through an endothelial EV-miRNA pathway (45). In addition to systemic cross-organ signaling, EV-miRNA communication also shapes local tissue remodeling. Fry et al (197) demonstrated that during mechanical overload-induced skeletal muscle hypertrophy, myogenic progenitor cells (MPCs) regulate the stromal microenvironment through exosome-mediated transfer of miR-206. MPC-derived exosomes delivered miR-206 to fibrogenic cells, suppressed its target gene ribosome binding protein 1 (Rrbp1), reduced collagen and other extracellular matrix-related transcripts, and thereby limited excessive fibrosis while supporting appropriate muscle remodeling. By contrast, loss of MPCs or disruption of miRNA processing/exosomal miR-206 signaling exacerbated extracellular matrix deposition and impaired remodeling quality. These findings establish a direct mechanistic axis linking mechanical loading, EV-mediated miRNA transfer, recipient-cell gene reprogramming, and tissue adaptation (197).

Although much of the available literature remains associative, several recent studies have begun to provide stronger functional support that exercise-responsive EV-miRNA cargoes can regulate recipient-cell gene programs and tissue adaptation (34,198). In particular, some reports now extend beyond descriptive profiling by linking exercise-induced changes in EV-miRNA cargo to downstream target repression and measurable phenotypic effects in recipient tissues. In a diabetic heart model, exercise-induced enrichment of EV-associated miR-455 was linked to reduced MMP9 expression and attenuation of extracellular matrix remodeling and myocardial dysfunction (146). Similarly, exercise-responsive exosomal miR-342-5p has been functionally linked with suppression of apoptosis-related targets and enhanced cardioprotection (45). Among the currently available examples, the MPC-derived exosomal miR-206/Rrbp1 axis provides especially direct support that EV-mediated miRNA transfer can reshape recipient-cell gene expression and local tissue remodeling (197). Nevertheless, direct evidence that specific exercise-responsive EV-miRNA cargoes induce canonical epigenetic remodeling in recipient tissues, rather than broader post-transcriptional or signaling changes, remains limited and warrants further investigation.

Unresolved challenges in EV research

Current studies suggest that exercise-induced EV remodeling may contribute to cross-organ metabolic adaptation, inflammatory regulation, and tissue protection, but the field remains largely at a transitional stage between descriptive observation and mechanistic validation (34,37,118,199). A major limitation is methodological heterogeneity, much of which arises from differences in EV isolation and characterization strategies. Commonly used EV isolation techniques include differential ultracentrifugation, size exclusion chromatography, and immunoaffinity-based isolation, each with distinct strengths and limitations in terms of recovery, purity, and subtype selectivity (200). In general, ultracentrifugation is widely used but may co-isolate contaminants, size exclusion chromatography often improves purity, and immunoaffinity-based approaches provide higher specificity for selected EV populations (201). Terminology remains inconsistent across studies, with EVs, exosomes, microvesicles, and small EVs often used interchangeably, even though isolation procedures alone are usually insufficient to define vesicle subtype with precision (202). As emphasized in the Minimal Information for Studies of Extracellular Vesicles (MISEV)2018 recommendations, no single method is universally optimal, and isolation procedures alone are often insufficient to define EV subtypes with precision (48). MISEV2018 therefore advocates the use of 'extracellular vesicle' as a generic term when subtype assignment remains uncertain, together with transparent reporting of isolation workflows, complementary characterization methods, inclusion of both positive and negative markers, and careful assessment of co-isolated non-vesicular contaminants. These considerations are particularly important in exercise-EV studies, where methodological variation can substantially affect the apparent abundance, composition, and inferred function of circulating EV preparations (48). In addition, plasma and serum contain lipoproteins, albumin, and protein-RNA complexes that overlap extensively with small EVs in size and physicochemical properties; when sample purity is inadequate, apparent changes in EV number or EV-miRNA cargo may be misinterpreted (203). Another critical source of confounding, particularly in training studies, is sampling time. Because circulating small EV dynamics can be rapid, samples collected too close to the final exercise bout may reflect acute release and clearance rather than true training-induced homeostatic remodeling, thereby obscuring the distinction between acute responses and chronic adaptation (66). At the same time, although numerous studies report exercise-associated changes in circulating miRNA profiles, direct evidence remains limited regarding their precise tissue origins, dominant carrier subtypes, destination organs, and functional uptake (37,65,204). Moving the field forward will therefore require more rigorous experimental design under the MISEV framework. This includes improved EV isolation and characterization using multi-step workflows, more systematic reporting of positive and negative markers as well as contamination indicators, and clearer separation of acute stress responses from chronic training adaptations through appropriate sampling windows (such as ≥24-48 h after the last exercise bout). Recent advances in multi-omics are also helping to refine EV characterization beyond particle counting and bulk marker detection (205). Integrative analyses combining proteomics, lipidomics, and surfaceome profiling can improve discrimination between circulating EVs and non-vesicular contaminants, while providing a more detailed molecular map of EV composition in human plasma (206). For the exercise-EV field, these approaches may be especially useful for resolving vesicle heterogeneity, identifying tissue-informative cargoes, and connecting EV remodeling with downstream metabolic and epigenetic effects. More importantly, tissue-specific tracing, single-particle profiling, and causal intervention studies will be needed to define the contribution of distinct EV subtypes to ncRNA-mediated inter-organ communication and to clarify how these signals intersect with DNA methylation, histone modification, chromatin accessibility, and transcriptional reprogramming (203).

An additional translational limitation is that much of the current mechanistic framework has been established in animal models or cell-based systems, whereas direct human evidence remains comparatively limited. In preclinical studies, exercise-derived EVs have been linked to specific miRNA cargoes, downstream target regulation, and functional effects in recipient tissues. By contrast, most human studies still rely on measurements of circulating EV abundance, surface markers, or cargo associations before and after exercise, without directly establishing tissue origin, target-organ delivery, cellular uptake, or causal contribution to physiological adaptation. As a result, although the available data strongly support the biological plausibility of EV-mediated exercise signaling, the extent to which these mechanisms operate in humans remains incompletely resolved. Bridging this gap will require better integration of mechanistic preclinical studies with rigorously designed human investigations that incorporate refined EV characterization, longitudinal sampling, and functional validation.

Overall, as methodological standardization, refined EV subtyping, and integrative multi-omics approaches continue to advance, research on the exercise-EV-miRNA-epigenetic axis is likely to move from predominantly descriptive association toward more reproducible and causally interpretable mechanistic investigation. Such progress will not only deepen our understanding of how exercise promotes systemic health and metabolic adaptation, but may also support the development of biomarkers of exercise responsiveness, more precise exercise prescriptions, and future exercise-mimetic strategies.

Conclusions

EVs have emerged as key mediators of the systemic benefits of exercise. Far from being passive by-products of cellular stress, they act as dynamic carriers of bioactive cargo, including proteins, metabolites, and regulatory ncRNAs, that transmit exercise-induced signals to recipient cells and reshape downstream signaling and gene expression. Both acute and chronic exercise induce context-dependent remodeling of EV abundance, origin, and cargo, influenced by factors such as exercise modality, intensity, timing, training status, and host characteristics. Among the various cargoes, miRNAs play a particularly pivotal role as mobile epigenetic regulators that link exercise to sustained changes in metabolism, inflammation, tissue repair, and organ protection (Fig. 2). Current evidence supports the exercise-EV-epigenetic axis as a meaningful framework for understanding long-term physiological adaptation. However, progress in the field is still constrained by methodological heterogeneity, inconsistent terminology, and limited mechanistic insight into EV biogenesis, targeting, and functional uptake. Addressing these challenges through rigorous standardization, refined EV characterization, and in vivo causal studies will be essential. A clearer understanding of exercise-derived EVs may not only deepen our mechanistic understanding of exercise adaptation, but also advance the development of biomarkers, precision exercise strategies, and EV-based therapeutic approaches. This overall framing is consistent with the synthesis in the present review, in which exercise remodels EV abundance, subtype distribution, and cargo, with miRNAs emerging as a functionally important component, while the field remains limited by heterogeneity and incomplete mechanistic validation.

Representative exercise-responsive
miRNAs enriched in EVs and their potential biological functions.
The schematic summarizes representative miRNAs carried by
exercise-responsive EVs from different cellular or
tissue-associated sources. Exercise may alter the abundance of
EV-associated miRNAs released from skeletal muscle-related cells,
endothelial cells, and cardiac-associated compartments. Skeletal
muscle-derived EV miRNAs, including miR-206, miR-181a-5p, miR-133b,
and miR-31, are implicated in muscle remodeling, satellite
cell-related repair, fibrogenic cell regulation, and exercise
capacity. Endothelial cell-derived EV miRNAs, such as miR-206,
miR-114a, miR-133b, and miR-342-5p, may contribute to vascular and
organ-protective responses, including protection against
ischemia-reperfusion injury. Cardiac-associated EV miRNAs,
including miR-29b and miR-455, have been linked to regulation of
extracellular matrix remodeling, fibrosis, and myocardial
dysfunction. Green and red symbols indicate reported upregulation
and downregulation, respectively. Together, these examples
illustrate how exercise-induced EV-miRNA remodeling may connect
local cellular responses with systemic tissue protection and
adaptive remodeling. EVs, extracellular vesicles; miR, microRNA;
MPC, myogenic progenitor cell; Rrbp1, ribosome binding protein 1;
MMP9, matrix metalloproteinase 9.

Figure 2

Representative exercise-responsive miRNAs enriched in EVs and their potential biological functions. The schematic summarizes representative miRNAs carried by exercise-responsive EVs from different cellular or tissue-associated sources. Exercise may alter the abundance of EV-associated miRNAs released from skeletal muscle-related cells, endothelial cells, and cardiac-associated compartments. Skeletal muscle-derived EV miRNAs, including miR-206, miR-181a-5p, miR-133b, and miR-31, are implicated in muscle remodeling, satellite cell-related repair, fibrogenic cell regulation, and exercise capacity. Endothelial cell-derived EV miRNAs, such as miR-206, miR-114a, miR-133b, and miR-342-5p, may contribute to vascular and organ-protective responses, including protection against ischemia-reperfusion injury. Cardiac-associated EV miRNAs, including miR-29b and miR-455, have been linked to regulation of extracellular matrix remodeling, fibrosis, and myocardial dysfunction. Green and red symbols indicate reported upregulation and downregulation, respectively. Together, these examples illustrate how exercise-induced EV-miRNA remodeling may connect local cellular responses with systemic tissue protection and adaptive remodeling. EVs, extracellular vesicles; miR, microRNA; MPC, myogenic progenitor cell; Rrbp1, ribosome binding protein 1; MMP9, matrix metalloproteinase 9.

Availability of data and materials

Not applicable.

Authors' contributions

XZ and BZ contributed to the study conception and design, data collection, figure drawing, and manuscript drafting. Both authors read and approved the final manuscript. Data authentication is not applicable.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Abbreviations:

JNK2

c-Jun N-terminal kinase 2

EMVs

endothelial-derived microvesicles

EPC

endothelial progenitor cell

EVs

extracellular vesicles

HSP

heat shock protein

IGF-1

insulin-like growth factor-1

AKT

protein kinase B

mTOR

mechanistic target of rapamycin

miRNA or miR

microRNA

MISEV

Minimal Information for Studies of Extracellular Vesicles

MMP9

matrix metalloproteinase 9

MPCs

myogenic progenitor cells

MVBs

multivesicular bodies

MVs

microvesicles

myomiRs

muscle-specific microRNAs

ncRNA

non-coding RNA

PMVs

platelet-derived microvesicles

Treg

regulatory T cell

Acknowledgements

Not applicable.

Funding

This work was supported by the Youth Project of Education of National Social Science Foundation of China: A study on the accurate model of traditional exercises for the intervention of juvenile myopia in the new era (grant no. CLA210279).

References

1 

Myers J, Prakash M, Froelicher V, Do D, Partington S and Atwood JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 346:793–801. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Vina J, Sanchis-Gomar F, Martinez-Bello V and Gomez-Cabrera MC: Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol. 167:1–12. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, Chan HT, Tsao CK, Tsai SP and Wu X: Minimum amount of physical activity for reduced mortality and extended life expectancy: A prospective cohort study. Lancet. 378:1244–1253. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Ling C and Rönn T: Epigenetics in human obesity and type 2 diabetes. Cell Metab. 29:1028–1044. 2019. View Article : Google Scholar : PubMed/NCBI

5 

McGee SL and Hargreaves M: Epigenetics and exercise. Trends Endocrinol Metab. 30:636–645. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Mendis S, Davis S and Norrving B: Organizational update: The world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 46:e121–e122. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Hayıroğlu M, Çınar T, Çinier G, Karakaya A, Yıldırım M, Güney BÇ, Öz A, Gündoğmuş PD, Ösken A, Özkan A, et al: The effect of 1-year mean step count on the change in the atherosclerotic cardiovascular disease risk calculation in patients with high cardiovascular risk: A sub-study of the LIGHT randomized clinical trial. Kardiol Pol. 79:1140–1142. 2021. View Article : Google Scholar

8 

Hayıroğlu M, Çınar T, Cilli Hayıroğlu S, Şaylık F, Uzun M and Tekkeşin AI: The role of smart devices and mobile application on the change in peak VO(2) in patients with high cardiovascular risk: A sub-study of the LIGHT randomised clinical trial. Acta Cardiol. 78:1000–1005. 2023. View Article : Google Scholar

9 

Yi J, Chen J, Yao X, Zhao Z, Niu X, Li X, Sun J, Ji Y, Shang T, Gong L, et al: Myokine-mediated muscle-organ interactions: Molecular mechanisms and clinical significance. Biochem Pharmacol. 242:1173262025. View Article : Google Scholar : PubMed/NCBI

10 

Smith JAB, Murach KA, Dyar KA and Zierath JR: Exercise metabolism and adaptation in skeletal muscle. Nat Rev Mol Cell Biol. 24:607–632. 2023. View Article : Google Scholar : PubMed/NCBI

11 

Mathieu M, Martin-Jaular L, Lavieu G and Théry C: Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI

12 

Wortzel I, Dror S, Kenific CM and Lyden D: Exosome-mediated metastasis: Communication from a distance. Dev Cell. 49:347–360. 2019. View Article : Google Scholar : PubMed/NCBI

13 

Walzik D, Wences Chirino TY, Zimmer P and Joisten N: Molecular insights of exercise therapy in disease prevention and treatment. Signal Transduct Target Ther. 9:1382024. View Article : Google Scholar : PubMed/NCBI

14 

Egan B and Zierath JR: Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 17:162–184. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Furrer R and Handschin C: Molecular aspects of the exercise response and training adaptation in skeletal muscle. Free Radic Biol Med. 223:53–68. 2024. View Article : Google Scholar : PubMed/NCBI

16 

Luo Z, Sun Y, Qi B, Lin J, Chen Y, Xu Y and Chen J: Human bone marrow mesenchymal stem cell-derived extracellular vesicles inhibit shoulder stiffness via let-7a/Tgfbr1 axis. Bioact Mater. 17:344–359. 2022.PubMed/NCBI

17 

Luo Z, Qi B, Sun Y, Chen Y, Lin J, Qin H, Wang N, Shi R, Shang X, Chen S and Chen J: Engineering Bioactive M2 macrophage-polarized, anti-inflammatory, miRNA-Based liposomes for functional muscle repair: From exosomal mechanisms to biomaterials. Small. 18:e22019572022. View Article : Google Scholar : PubMed/NCBI

18 

Sun Y, Luo Z, Chen Y, Lin J, Zhang Y, Qi B and Chen J: si-Tgfbr1-loading liposomes inhibit shoulder capsule fibrosis via mimicking the protective function of exosomes from patients with adhesive capsulitis. Biomater Res. 26:392022. View Article : Google Scholar : PubMed/NCBI

19 

Raposo G and Stoorvogel W: Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol. 200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Hugel B, Martínez MC, Kunzelmann C and Freyssinet JM: Membrane microparticles: Two sides of the coin. Physiology (Bethesda). 20:22–27. 2005.PubMed/NCBI

21 

Smalley DM, Sheman NE, Nelson K and Theodorescu D: Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res. 7:2088–2096. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Erdbrügger U and Lannigan J: Analytical challenges of extracellular vesicle detection: A comparison of different techniques. Cytometry A. 89:123–134. 2016. View Article : Google Scholar

23 

Zhang Y, Lan M and Chen Y: Minimal information for studies of extracellular vesicles (MISEV): Ten-year evolution (2014-2023). Pharmaceutics. 16:13942024. View Article : Google Scholar : PubMed/NCBI

24 

Vaiaki EM and Falasca M: Comparative analysis of the minimal information for studies of extracellular vesicles guidelines: Advancements and implications for extracellular vesicle research. Semin Cancer Biol. 101:12–24. 2024. View Article : Google Scholar : PubMed/NCBI

25 

Silvestri M, Grazioli E, Duranti G, Sgrò P and Dimauro I: Exploring the impact of exercise-derived extracellular vesicles in cancer biology. Biology (Basel). 13:7012024.PubMed/NCBI

26 

Whitham M, Parker BL, Friedrichsen M, Hingst JR, Hjorth M, Hughes WE, Egan CL, Cron L, Watt KI, Kuchel RP, et al: Extracellular vesicles provide a means for tissue crosstalk during exercise. Cell Metab. 27:237–251.e4. 2018. View Article : Google Scholar : PubMed/NCBI

27 

Nederveen JP, Warnier G, Di Carlo A, Nilsson MI and Tarnopolsky MA: Extracellular vesicles and exosomes: insights from exercise science. Front Physiol. 11:6042742021. View Article : Google Scholar : PubMed/NCBI

28 

Chen Y, Hong T, Wang S, Mo J, Tian T and Zhou X: Epigenetic modification of nucleic acids: From basic studies to medical applications. Chem Soc Rev. 46:2844–2872. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Wu YL, Lin ZJ, Li CC, Lin X, Shan SK, Guo B, Zheng MH, Li F, Yuan LQ and Li ZH: Epigenetic regulation in metabolic diseases: Mechanisms and advances in clinical study. Signal Transduct Target Ther. 8:982023. View Article : Google Scholar : PubMed/NCBI

30 

Dimauro I, Paronetto MP and Caporossi D: Exercise, redox homeostasis and the epigenetic landscape. Redox Biol. 35:1014772020. View Article : Google Scholar : PubMed/NCBI

31 

Oh ES and Petronis A: Origins of human disease: The chrono-epigenetic perspective. Nat Rev Genet. 22:533–546. 2021. View Article : Google Scholar : PubMed/NCBI

32 

Zhou H, Hu S and Yan W: Extracellular vesicles as modifiers of epigenomic profiles. Trends Genet. 40:797–809. 2024. View Article : Google Scholar : PubMed/NCBI

33 

Jiang S, Kang S, Kwon O, Seo W, Jin EJ, Ha H and Huh JY: Small extracellular vesicles derived from damaged muscle aggravate kidney injury progression. J Cachexia Sarcopenia Muscle. 16:e138612025. View Article : Google Scholar : PubMed/NCBI

34 

Pinto-Hernandez P, Fernandez-Sanjurjo M, Paget D, Caravia XM, Roiz-Valle D, Castilla-Silgado J, Diez-Robles S, Coto-Vilcapoma A, Fernandez-Vivero D, Gama-Perez P, et al: Training-induced plasma miR-29a-3p is secreted by skeletal muscle and contributes to metabolic adaptations to resistance exercise in mice. Mol Metab. 98:1021732025. View Article : Google Scholar : PubMed/NCBI

35 

Zhang Y, Wei Y, Liu H and Guo Y: Protective effect of exercise on metabolic dysfunction-associated fatty liver disease: Potential epigenetic mechanisms (Review). Int J Mol Med. 56:1462025. View Article : Google Scholar

36 

Safdar A, Saleem A and Tarnopolsky MA: The potential of endurance exercise-derived exosomes to treat metabolic diseases. Nat Rev Endocrinol. 12:504–517. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Li H, Liu G, Wang B and Momeni MR: Exosomes and microRNAs as mediators of the exercise. Eur J Med Res. 30:382025. View Article : Google Scholar : PubMed/NCBI

38 

Joaquim VHA, Pereira NP, Improta-Caria AC, de Avila Pelozin BR, Fernandes T and Oliveira EM: Exosomes and microRNAs: Molecular mediators linking obesity, exercise, and metabolic regulation. Curr Diab Rep. 25:552025. View Article : Google Scholar : PubMed/NCBI

39 

Cheng L and Hill AF: Therapeutically harnessing extracellular vesicles. Nat Rev Drug Discov. 21:379–399. 2022. View Article : Google Scholar : PubMed/NCBI

40 

Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, Fang X and Zhang X: Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 21:562022. View Article : Google Scholar : PubMed/NCBI

41 

Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, et al: Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 13:e124042024. View Article : Google Scholar : PubMed/NCBI

42 

Park S and Moon HY: Urinary extracellular vesicle as a potential biomarker of exercise-induced fatigue in young adult males. Eur J Appl Physiol. 122:2175–2188. 2022. View Article : Google Scholar : PubMed/NCBI

43 

Zhang X, Kraus WE, Houmard JA, Johnson JL and Kraus VB: Plasma extracellular vesicle signatures of metabolic health and exercise response in a pilot study of older adults. Am J Physiol Cell Physiol. 330:C379–C389. 2026. View Article : Google Scholar :

44 

Bei Y, Xu T, Lv D, Yu P, Xu J, Che L, Das A, Tigges J, Toxavidis V, Ghiran I, et al: Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury. Basic Res Cardiol. 112:382017. View Article : Google Scholar : PubMed/NCBI

45 

Hou Z, Qin X, Hu Y, Zhang X, Li G, Wu J, Li J, Sha J, Chen J, Xia J, et al: Longterm exercise-derived exosomal miR-342-5p: A novel exerkine for cardioprotection. Circ Res. 124:1386–1400. 2019. View Article : Google Scholar : PubMed/NCBI

46 

Wolf P: The nature and significance of platelet products in human plasma. Br J Haematol. 13:269–288. 1967. View Article : Google Scholar : PubMed/NCBI

47 

Johnstone RM, Mathew A, Mason AB and Teng K: Exosome formation during maturation of mammalian and avian reticulocytes: Evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol. 147:27–36. 1991. View Article : Google Scholar : PubMed/NCBI

48 

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al: Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018. View Article : Google Scholar

49 

Johnstone RM, Adam M, Hammond JR, Orr L and Turbide C: Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 262:9412–9420. 1987. View Article : Google Scholar : PubMed/NCBI

50 

Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S, Quesenberry P, et al: Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for extracellular vesicles. J Extracell Vesicles. 3:269132014. View Article : Google Scholar : PubMed/NCBI

51 

Xiang H, Bao C, Chen Q, Gao Q, Wang N, Gao Q and Mao L: Extracellular vesicles (EVs)' journey in recipient cells: From recognition to cargo release. J Zhejiang Univ Sci B. 25:633–655. 2024.In English, Chinese. View Article : Google Scholar : PubMed/NCBI

52 

Rilla K, Pasonen-Seppänen S, Deen AJ, Koistinen VVT, Wojciechowski S, Oikari S, Kärnä R, Bart G, Törrönen K, Tammi RH and Tammi MI: Hyaluronan production enhances shedding of plasma membrane-derived microvesicles. Exp Cell Res. 319:2006–2018. 2013. View Article : Google Scholar : PubMed/NCBI

53 

György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al: Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell Mol Life Sci. 68:2667–2688. 2011. View Article : Google Scholar : PubMed/NCBI

54 

McCullough J, Fisher RD, Whitby FG, Sundquist WI and Hill CP: ALIX-CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad Sci USA. 105:7687–7691. 2008. View Article : Google Scholar : PubMed/NCBI

55 

Gurung S, Perocheau D, Touramanidou L and Baruteau J: The exosome journey: From biogenesis to uptake and intracellular signalling. Cell Commun Signal. 19:472021. View Article : Google Scholar : PubMed/NCBI

56 

Lee YJ, Shin KJ and Chae YC: Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 56:877–889. 2024. View Article : Google Scholar : PubMed/NCBI

57 

Hou S, Wang L, Yang C, Li Y and Liu H: MACC1 drives metastasis in colorectal cancer by coordinating YKT6-dependent exosome biogenesis and c-Met cargo selection. Cell Signal. 135:1120732025. View Article : Google Scholar : PubMed/NCBI

58 

Arya SB, Collie SP and Parent CA: The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol. 34:90–108. 2024. View Article : Google Scholar

59 

Wei H, Chen Q, Lin L, Sha C, Li T, Liu Y, Yin X, Xu Y, Chen L, Gao W, et al: Regulation of exosome production and cargo sorting. Int J Biol Sci. 17:163–177. 2021. View Article : Google Scholar : PubMed/NCBI

60 

Navasiolava NM, Dignat-George F, Sabatier F, Larina IM, Demiot C, Fortrat JO, Gauquelin-Koch G, Kozlovskaya IB and Custaud MA: Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers. Am J Physiol Heart Circ Physiol. 299:H248–H256. 2010. View Article : Google Scholar : PubMed/NCBI

61 

Ni P, Yang L and Li F: Exercise-derived skeletal myogenic exosomes as mediators of intercellular crosstalk: A major player in health, disease, and exercise. J Physiol Biochem. 79:501–510. 2023. View Article : Google Scholar : PubMed/NCBI

62 

Blank M, Israeli D and Shoenfeld Y: Exercise, autoimmune diseases and T-regulatory cells. J Autoimmun. 149:1033172024. View Article : Google Scholar : PubMed/NCBI

63 

Sukhnanan K, Ross JR, Chao NJ and Chen BJ: Endothelial cell derived extracellular vesicles and hematopoiesis. Radiat Res. 202:215–226. 2024. View Article : Google Scholar : PubMed/NCBI

64 

Tao SC, Guo SC and Zhang CQ: Platelet-derived extracellular vesicles: An emerging therapeutic approach. Int J Biol Sci. 13:828–834. 2017. View Article : Google Scholar : PubMed/NCBI

65 

Eichner NZM, Erdbrügger U and Malin SK: Extracellular vesicles: A novel target for exercise-mediated reductions in type 2 diabetes and cardiovascular disease risk. J Diabetes Res. 2018:78072452018. View Article : Google Scholar : PubMed/NCBI

66 

Caporossi D, Jackson MJ and Henriquez-Olguin C: Intracellular and extracellular redox signals during exercise and aging. Free Radic Biol Med. 242:521–534. 2026. View Article : Google Scholar

67 

Pedersen BK and Febbraio MA: Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol. 8:457–465. 2012. View Article : Google Scholar : PubMed/NCBI

68 

Guescini M, Canonico B, Lucertini F, Maggio S, Annibalini G, Barbieri E, Luchetti F, Papa S and Stocchi V: Muscle releases alpha-sarcoglycan positive extracellular vesicles carrying miRNAs in the Bloodstream. PLoS One. 10:e01250942015. View Article : Google Scholar : PubMed/NCBI

69 

Jalabert A, Vial G, Guay C, Wiklander OP, Nordin JZ, Aswad H, Forterre A, Meugnier E, Pesenti S, Regazzi R, et al: Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice. Diabetologia. 59:1049–1058. 2016. View Article : Google Scholar : PubMed/NCBI

70 

Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, Granjon A, Errazuriz E, Lefai E, Vidal H and Rome S: Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle. 13:78–89. 2014. View Article : Google Scholar

71 

Liu HC, Han DS, Hsu CC and Wang JS: Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults. BMC Geriatr. 21:862021. View Article : Google Scholar : PubMed/NCBI

72 

Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E and Ambros V: Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5:R132004. View Article : Google Scholar : PubMed/NCBI

73 

Yin X, Zhao Y, Zheng YL, Wang JZ, Li W, Lu QJ, Huang QN, Zhang CY, Chen X and Ma JZ: Time-course responses of muscle-specific MicroRNAs following acute uphill or downhill exercise in sprague-dawley rats. Front Physiol. 10:12752019. View Article : Google Scholar : PubMed/NCBI

74 

Aoi W and Tanimura Y: Roles of skeletal muscle-derived exosomes in organ metabolic and immunological communication. Front Endocrinol (Lausanne). 12:6972042021. View Article : Google Scholar : PubMed/NCBI

75 

Madison RD, McGee C, Rawson R and Robinson GA: Extracellular vesicles from a muscle cell line (C2C12) enhance cell survival and neurite outgrowth of a motor neuron cell line (NSC-34). J Extracell Vesicles. 3:2014. View Article : Google Scholar : PubMed/NCBI

76 

Wu Z, Gao Y, Chen Q and Yuan L: Inter-Organ crosstalk and regulatory mechanisms of skeletal muscle-derived extracellular vesicles in systemic metabolic homeostasis. J Cell Mol Med. 29:e708962025. View Article : Google Scholar : PubMed/NCBI

77 

Matsuzaka Y, Tanihata J, Komaki H, Ishiyama A, Oya Y, Rüegg U, Takeda SI and Hashido K: Characterization and functional analysis of extracellular vesicles and muscle-abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice. PLoS One. 11:e01678112016. View Article : Google Scholar : PubMed/NCBI

78 

Zhang A, Li M, Wang B, Klein JD, Price SR and Wang XH: miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk. J Cachexia Sarcopenia Muscle. 9:755–770. 2018. View Article : Google Scholar : PubMed/NCBI

79 

Noboa-Velástegui JA, Valdez-Vega RI, Castro-Albarran J, Madrigal-Ruiz PM, Fletes-Rayas AL, Ruiz-Quezada SL, Ramos-Márquez ME, López-Jiménez JJ, Álvarez I and Navarro-Hernández RE: Expression of serum and exosomal microRNA-34a in subjects with increased fat mass. Int J Mol Sci. 27:2702025. View Article : Google Scholar

80 

Roberts TC, Godfrey C, McClorey G, Vader P, Briggs D, Gardiner C, Aoki Y, Sargent I, Morgan JE and Wood MJ: Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res. 41:9500–9513. 2013. View Article : Google Scholar : PubMed/NCBI

81 

Cacchiarelli D, Legnini I, Martone J, Cazzella V, D'Amico A, Bertini E and Bozzoni I: miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med. 3:258–265. 2011. View Article : Google Scholar : PubMed/NCBI

82 

Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, Sum CF and Jeyaseelan K: MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 6:e228392011. View Article : Google Scholar : PubMed/NCBI

83 

Donaldson A, Natanek SA, Lewis A, Man WD, Hopkinson NS, Polkey M and Kemp PR: Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax. 68:1140–1149. 2013. View Article : Google Scholar : PubMed/NCBI

84 

Miyachi M, Tsuchiya K, Yoshida H, Yagyu S, Kikuchi K, Misawa A, Iehara T and Hosoi H: Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun. 400:89–93. 2010. View Article : Google Scholar : PubMed/NCBI

85 

Sossdorf M, Otto GP, Claus RA, Gabriel HH and Lösche W: Release of pro-coagulant microparticles after moderate endurance exercise. Platelets. 21:389–391. 2010. View Article : Google Scholar : PubMed/NCBI

86 

Sossdorf M, Otto GP, Claus RA, Gabriel HH and Lösche W: Cell-derived microparticles promote coagulation after moderate exercise. Med Sci Sports Exerc. 43:1169–1176. 2011. View Article : Google Scholar

87 

Headland SE, Jones HR, D'Sa AS, Perretti M and Norling LV: Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 4:52372014. View Article : Google Scholar : PubMed/NCBI

88 

Keir DA, Fontana FY, Robertson TC, Murias JM, Paterson DH, Kowalchuk JM and Pogliaghi S: Exercise intensity thresholds: Identifying the boundaries of sustainable performance. Med Sci Sports Exerc. 47:1932–1940. 2015. View Article : Google Scholar : PubMed/NCBI

89 

Guiraud T, Gayda M, Juneau M, Bosquet L, Meyer P, Théberge-Julien G, Galinier M, Nozza A, Lambert J, Rhéaume E, et al: A single bout of high-intensity interval exercise does not increase endothelial or platelet microparticles in stable, physically fit men with coronary heart disease. Can J Cardiol. 29:1285–1291. 2013.PubMed/NCBI

90 

Maruyama K, Kadono T and Morishita E: Plasma levels of platelet-derived microparticles are increased after anaerobic exercise in healthy subjects. J Atheroscler Thromb. 19:585–587. 2012. View Article : Google Scholar : PubMed/NCBI

91 

Lansford KA, Shill DD, Dicks AB, Marshburn MP, Southern WM and Jenkins NT: Effect of acute exercise on circulating angiogenic cell and microparticle populations. Exp Physiol. 101:155–167. 2016. View Article : Google Scholar

92 

Wilhelm EN, González-Alonso J, Parris C and Rakobowchuk M: Exercise intensity modulates the appearance of circulating microvesicles with proangiogenic potential upon endothelial cells. Am J Physiol Heart Circ Physiol. 311:H1297–H1310. 2016. View Article : Google Scholar : PubMed/NCBI

93 

Kirk RJ, Peart DJ, Madden LA and Vince RV: Repeated supra-maximal sprint cycling with and without sodium bicarbonate supplementation induces endothelial microparticle release. Eur J Sport Sci. 14:345–352. 2014. View Article : Google Scholar

94 

Möbius-Winkler S, Hilberg T, Menzel K, Golla E, Burman A, Schuler G and Adams V: Time-dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. J Appl Physiol (1985). 107:1943–1950. 2009. View Article : Google Scholar : PubMed/NCBI

95 

Wahl P, Jansen F, Achtzehn S, Schmitz T, Bloch W, Mester J and Werner N: Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors. PLoS One. 9:e960242014. View Article : Google Scholar : PubMed/NCBI

96 

Wilhelm EN, Mourot L and Rakobowchuk M: Exercise-Derived microvesicles: A review of the literature. Sports Med. 48:2025–2039. 2018. View Article : Google Scholar : PubMed/NCBI

97 

Lin C, Guo J and Jia R: Roles of regulatory T cell-derived extracellular vesicles in human diseases. Int J Mol Sci. 23:112062022. View Article : Google Scholar : PubMed/NCBI

98 

Azimi M, Ghabaee M, Moghadasi AN, Noorbakhsh F and Izad M: Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis. Immunol Res. 66:513–520. 2018. View Article : Google Scholar : PubMed/NCBI

99 

Punga AR, Andersson M, Alimohammadi M and Punga T: Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients. J Neurol Sci. 356:90–96. 2015. View Article : Google Scholar : PubMed/NCBI

100 

Lovinsky-Desir S, Jung KH, Jezioro JR, Torrone DZ, de Planell-Saguer M, Yan B, Perera FP, Rundle AG, Perzanowski MS, Chillrud SN and Miller RL: Physical activity, black carbon exposure, and DNA methylation in the FOXP3 promoter. Clin Epigenetics. 9:652017. View Article : Google Scholar : PubMed/NCBI

101 

Catitti G, De Bellis D, Vespa S, Simeone P, Canonico B and Lanuti P: Extracellular vesicles as players in the anti-inflammatory inter-cellular crosstalk induced by exercise training. Int J Mol Sci. 23:140982022. View Article : Google Scholar : PubMed/NCBI

102 

Darkwah S, Park EJ, Myint PK, Ito A, Appiah MG, Obeng G, Kawamoto E and Shimaoka M: Potential roles of muscle-derived extracellular vesicles in remodeling cellular microenvironment: proposed implications of the exercise-induced myokine, irisin. Front Cell Dev Biol. 9:6348532021. View Article : Google Scholar : PubMed/NCBI

103 

Jiang T, Huang Y, Liu H, Xu Q, Gong Y, Chen Y, Hu X, Han Z and Gao M: Reduced miR-146a promotes REG3A expression and macrophage migration in polymyositis and dermatomyositis. Front Immunol. 11:372020. View Article : Google Scholar : PubMed/NCBI

104 

Petriz BA, Gomes CP, Almeida JA, de Oliveira GP Jr, Ribeiro FM, Pereira RW and Franco OL: The effects of acute and chronic exercise on skeletal muscle proteome. J Cell Physiol. 232:257–269. 2017. View Article : Google Scholar

105 

Fine J: Exercise and fitness. JAMA. 188:433–436. 1964. View Article : Google Scholar : PubMed/NCBI

106 

Thyfault JP and Bergouignan A: Exercise and metabolic health: Beyond skeletal muscle. Diabetologia. 63:1464–1474. 2020. View Article : Google Scholar : PubMed/NCBI

107 

Papaioannou F, Karatzanos E, Chatziandreou I, Philippou A, Nanas S and Dimopoulos S: Epigenetic effects following acute and chronic exercise in cardiovascular disease: A systematic review. Int J Cardiol. 341:88–95. 2021. View Article : Google Scholar : PubMed/NCBI

108 

Mora JC and Valencia WM: Exercise and older adults. Clin Geriatr Med. 34:145–162. 2018. View Article : Google Scholar

109 

Andrade C: Physical exercise and health, 2: Benefits associated with different levels and patterns of activity. J Clin Psychiatry. 84:23f151102023. View Article : Google Scholar : PubMed/NCBI

110 

Frühbeis C, Helmig S, Tug S, Simon P and Krämer-Albers EM: Physical exercise induces rapid release of small extracellular vesicles into the circulation. J Extracell Vesicles. 4:282392015. View Article : Google Scholar : PubMed/NCBI

111 

Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, Febbraio MA, Galis ZS, Gao Y, Haus JM, et al: Exerkines in health, resilience and disease. Nat Rev Endocrinol. 18:273–289. 2022. View Article : Google Scholar : PubMed/NCBI

112 

Kong H, Zheng J, Han J, Meng X, Li X, Wang X and Zhang XA: The crosstalk among macrophages, chondrocytes and mesenchymal stem cells in osteoarthritis: The role of extracellular vesicles. Stem Cell Res Ther. 16:5532025. View Article : Google Scholar : PubMed/NCBI

113 

Wu Y, Hou M, Deng Y, Xia X, Liu Y, Yu J, Yu C, Yang H, Zhang Y and Zhu X: Swimming exercise induces redox-lipid crosstalk to ameliorate osteoarthritis progression. Redox Biol. 81:1035352025. View Article : Google Scholar : PubMed/NCBI

114 

Vechetti IJ Jr, Valentino T, Mobley CB and McCarthy JJ: The role of extracellular vesicles in skeletal muscle and systematic adaptation to exercise. J Physiol. 599:845–861. 2021. View Article : Google Scholar :

115 

Safdar A and Tarnopolsky MA: Exosomes as mediators of the systemic adaptations to endurance exercise. Cold Spring Harb Perspect Med. 8:a0298272018. View Article : Google Scholar

116 

Lombardo M, Aiello G, Fratantonio D, Karav S and Baldelli S: Functional role of extracellular vesicles in skeletal muscle physiology and sarcopenia: the importance of physical exercise and nutrition. Nutrients. 16:30972024. View Article : Google Scholar : PubMed/NCBI

117 

D'Souza RF, Woodhead JST, Zeng N, Blenkiron C, Merry TL, Cameron-Smith D and Mitchell CJ: Circulatory exosomal miRNA following intense exercise is unrelated to muscle and plasma miRNA abundances. Am J Physiol Endocrinol Metab. 315:E723–E733. 2018. View Article : Google Scholar : PubMed/NCBI

118 

Estébanez B, Jiménez-Pavón D, Huang CJ, Cuevas MJ and González-Gallego J: Effects of exercise on exosome release and cargo in in vivo and ex vivo models: A systematic review. J Cell Physiol. 236:3336–3353. 2021. View Article : Google Scholar

119 

Egan B and Sharples AP: Molecular responses to acute exercise and their relevance for adaptations in skeletal muscle to exercise training. Physiol Rev. 103:2057–2170. 2023. View Article : Google Scholar

120 

Karpovich PV: Exercise. Annu Rev Physiol. 9:149–162. 1947. View Article : Google Scholar : PubMed/NCBI

121 

Thomas HJ, Ang T, Morrison DJ, Keske MA and Parker L: Acute exercise and high-glucose ingestion elicit dynamic and individualized responses in systemic markers of redox homeostasis. Front Immunol. 14:11270882023. View Article : Google Scholar : PubMed/NCBI

122 

Morgan WP: Affective beneficence of vigorous physical activity. Med Sci Sports Exerc. 17:94–100. 1985. View Article : Google Scholar : PubMed/NCBI

123 

Hammerman H, Schoen FJ and Kloner RA: Short-term exercise has a prolonged effect on scar formation after experimental acute myocardial infarction. J Am Coll Cardiol. 2:979–982. 1983. View Article : Google Scholar : PubMed/NCBI

124 

Díaz-Castro F, Tuñón-Suárez M, Rivera P, Botella J, Cancino J, Figueroa AM, Gutiérrez J, Cantin C, Deldicque L, Zbinden-Foncea H, et al: A single bout of resistance exercise triggers mitophagy, potentially involving the ejection of mitochondria in human skeletal muscle. Acta Physiol (Oxf). 240:e142032024. View Article : Google Scholar

125 

Brown EC, Franklin BA, Regensteiner JG and Stewart KJ: Effects of single bout resistance exercise on glucose levels, insulin action, and cardiovascular risk in type 2 diabetes: A narrative review. J Diabetes Complications. 34:1076102020. View Article : Google Scholar : PubMed/NCBI

126 

Bittel AJ, Bittel DC, Mittendorfer B, Patterson BW, Okunade AL, Yoshino J, Porter LC, Abumrad NA, Reeds DN and Cade WT: A single bout of resistance exercise improves postprandial lipid metabolism in overweight/obese men with prediabetes. Diabetologia. 63:611–623. 2020. View Article : Google Scholar

127 

Feng W, Yu WL, Zhao Z, Guo YD, Zhou XJ, Zhai KQ, Liu X and Yan ZW: Acute effects of high-intensity interval exercise and moderate-intensity continuous training on arterial stiffness and endothelial function in hypertension: A crossover trial. Sci Rep. 15:370862025. View Article : Google Scholar : PubMed/NCBI

128 

Pedersen BK and Hoffman-Goetz L: Exercise and the immune system: Regulation, integration, and adaptation. Physiol Rev. 80:1055–1081. 2000. View Article : Google Scholar : PubMed/NCBI

129 

Siqueira IR, Palazzo RP and Cechinel LR: Circulating extracellular vesicles delivering beneficial cargo as key players in exercise effects. Free Radic Biol Med. 172:273–285. 2021. View Article : Google Scholar : PubMed/NCBI

130 

Helmig S, Frühbeis C, Krämer-Albers EM, Simon P and Tug S: Release of bulk cell free DNA during physical exercise occurs independent of extracellular vesicles. Eur J Appl Physiol. 115:2271–2280. 2015. View Article : Google Scholar : PubMed/NCBI

131 

Oliveira GP Jr, Porto WF, Palu CC, Pereira LM, Petriz B, Almeida JA, Viana J, Filho NNA, Franco OL and Pereira RW: Effects of acute aerobic exercise on rats serum extracellular vesicles diameter, concentration and small RNAs content. Front Physiol. 9:5322018. View Article : Google Scholar : PubMed/NCBI

132 

Brahmer A, Neuberger E, Esch-Heisser L, Haller N, Jorgensen MM, Baek R, Möbius W, Simon P and Krämer-Albers EM: Platelets, endothelial cells and leukocytes contribute to the exercise-triggered release of extracellular vesicles into the circulation. J Extracell Vesicles. 8:16158202019. View Article : Google Scholar : PubMed/NCBI

133 

Rigamonti AE, Bollati V, Pergoli L, Iodice S, De Col A, Tamini S, Cicolini S, Tringali G, De Micheli R, Cella SG and Sartorio A: Effects of an acute bout of exercise on circulating extracellular vesicles: tissue-, sex-, and BMI-related differences. Int J Obes (Lond). 44:1108–1118. 2020. View Article : Google Scholar

134 

Sapp RM, Shill DD, Roth SM and Hagberg JM: Circulating microRNAs in acute and chronic exercise: more than mere biomarkers. J Appl Physiol (1985). 122:702–717. 2017. View Article : Google Scholar

135 

Bass H, Whitcomb JF and Forman R: Exercise training: Therapy for patients with chronic obstructive pulmonary disease. Chest. 57:116–121. 1970. View Article : Google Scholar : PubMed/NCBI

136 

Balietti M, Fattoretti P, Skalicky M, Viidik A, Giorgetti B, Grossi Y and Bertoni-Freddari C: The effect of chronic physical exercise on succinic dehydrogenase activity in the heart muscle of old rats. Biogerontology. 6:95–100. 2005. View Article : Google Scholar : PubMed/NCBI

137 

Liu J, Xiao F, Choubey A, Kumar SU, Wang Y, Hong S, Yang T, Otlu HG, Oturmaz ES, Loro E, et al: Muscle Rev-erb controls time-dependent adaptations to chronic exercise in mice. Nat Commun. 16:57082025. View Article : Google Scholar : PubMed/NCBI

138 

Mackinnon LT: Chronic exercise training effects on immune function. Med Sci Sports Exerc. 32(Suppl 7): S369–S376. 2000. View Article : Google Scholar : PubMed/NCBI

139 

Audiffren M and André N: The exercise-cognition relationship: A virtuous circle. J Sport Health Sci. 8:339–347. 2019. View Article : Google Scholar : PubMed/NCBI

140 

Ploeger HE, Takken T, de Greef MH and Timmons BW: The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: A systematic review. Exerc Immunol Rev. 15:6–41. 2009.PubMed/NCBI

141 

Fedewa MV, Hathaway ED, Ward-Ritacco CL, Williams TD and Dobbs WC: The effect of chronic exercise training on leptin: A systematic review and meta-analysis of Randomized controlled trials. Sports Med. 48:1437–1450. 2018. View Article : Google Scholar : PubMed/NCBI

142 

Brennan AM, Benson M, Morningstar J, Herzig M, Robbins J, Gerszten RE and Ross R: Plasma metabolite profiles in response to chronic exercise. Med Sci Sports Exerc. 50:1480–1486. 2018. View Article : Google Scholar : PubMed/NCBI

143 

de Las Heras N, Klett-Mingo M, Ballesteros S, Martín-Fernández B, Escribano Ó, Blanco-Rivero J, Balfagón G, Hribal ML, Benito M, Lahera V and Gómez-Hernández A: Chronic exercise improves mitochondrial function and insulin sensitivity in brown adipose tissue. Front Physiol. 9:11222018. View Article : Google Scholar : PubMed/NCBI

144 

Joisten N, Walzik D, Metcalfe AJ, Bloch W and Zimmer P: Physical exercise as kynurenine pathway modulator in chronic diseases: Implications for immune and energy homeostasis. Int J Tryptophan Res. 13:11786469209386882020. View Article : Google Scholar : PubMed/NCBI

145 

Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS and Nimmo MA: The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 11:607–615. 2011. View Article : Google Scholar : PubMed/NCBI

146 

Bertoldi K, Cechinel LR, Schallenberger B, Corssac GB, Davies S, Guerreiro ICK, Belló-Klein A, Araujo ASR and Siqueira IR: Circulating extracellular vesicles in the aging process: Impact of aerobic exercise. Mol Cell Biochem. 440:115–125. 2018. View Article : Google Scholar

147 

Chaturvedi P, Kalani A, Medina I, Familtseva A and Tyagi SC: Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise. J Cell Mol Med. 19:2153–2161. 2015. View Article : Google Scholar : PubMed/NCBI

148 

Mastrototaro L, Apostolopoulou M, Hartwig S, Strassburger K, Lipaeva P, Trinks N, Karusheva Y, Gancheva S, Trenkamp S, Lehr S, et al: The role of exosomes for sustained specific cardiorespiratory and metabolic improvements in males with type 2 diabetes after detraining. EBioMedicine. 110:1054712024. View Article : Google Scholar : PubMed/NCBI

149 

Warnier G, van Doorslaer de Ten Ryen S, Lannoy C, Mahy T, Antoine N, Boyer E, Kienlen-Campard P, Verboven K, Copine S, Francaux M and Deldicque L: Effect of a 12-Week endurance training program on circulating extracellular vesicle proteome in sedentary adults with obesity. J Extracell Biol. 4:e700872025. View Article : Google Scholar : PubMed/NCBI

150 

Ma C, Wang J, Liu H, Chen Y, Ma X, Chen S, Chen Y, Bihl JI and Yang YI: Moderate exercise enhances endothelial progenitor cell exosomes release and function. Med Sci Sports Exerc. 50:2024–2032. 2018. View Article : Google Scholar : PubMed/NCBI

151 

Barone R, Macaluso F, Sangiorgi C, Campanella C, Marino Gammazza A, Moresi V, Coletti D, Conway de Macario E, Macario AJ, Cappello F, et al: Skeletal muscle Heat shock protein 60 increases after endurance training and induces peroxisome proliferator-activated receptor gamma coactivator 1 α1 expression. Sci Rep. 6:197812016. View Article : Google Scholar

152 

Kalluri R: The biology and function of extracellular vesicles in immune response and immunity. Immunity. 57:1752–1768. 2024. View Article : Google Scholar : PubMed/NCBI

153 

Joshi BS, de Beer MA, Giepmans BNG and Zuhorn IS: Endocytosis of extracellular vesicles and release of their cargo from endosomes. ACS Nano. 14:4444–4455. 2020. View Article : Google Scholar : PubMed/NCBI

154 

Guo Q, Chen J, Wu J, Mo Z, Ye L, Zhong W, Zhang Y, Lai H, Zhang Y, Qiu J, et al: Bioprinted mesenchymal stem cell microfiber-derived extracellular vesicles alleviate unilateral renal ischemia-reperfusion injury and fibrosis by inhibiting tubular epithelial cells ferroptosis. Bioact Mater. 40:649–664. 2024.PubMed/NCBI

155 

Gao H, Zeng Y, Huang X, A L, Liang Q, Xie J, Lin X, Gong J, Fan X, Zou T and Xu H: Extracellular vesicles from organoid-derived human retinal progenitor cells prevent lipid overload-induced retinal pigment epithelium injury by regulating fatty acid metabolism. J Extracell Vesicles. 13:e124012024. View Article : Google Scholar

156 

Zhao Q, Li B, Zhang X, Zhao H, Xue W, Yuan Z, Xu S and Duan G: M2 macrophage-derived lncRNA NORAD in EVs promotes NSCLC progression via miR-520g-3p/SMIM22/GALE axis. NPJ Precis Oncol. 8:1852024. View Article : Google Scholar : PubMed/NCBI

157 

Muraca M and Cappariello A: The role of extracellular vesicles (EVs) in the epigenetic regulation of bone metabolism and osteoporosis. Int J Mol Sci. 21:86822020. View Article : Google Scholar : PubMed/NCBI

158 

Man K, Brunet MY, Fernandez-Rhodes M, Williams S, Heaney LM, Gethings LA, Federici A, Davies OG, Hoey D and Cox SC: Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast-derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation. J Extracell Vesicles. 10:e121182021. View Article : Google Scholar : PubMed/NCBI

159 

Cavalli G and Heard E: Advances in epigenetics link genetics to the environment and disease. Nature. 571:489–499. 2019. View Article : Google Scholar : PubMed/NCBI

160 

Pal S and Tyler JK: Epigenetics and aging. Sci Adv. 2:e16005842016. View Article : Google Scholar : PubMed/NCBI

161 

Wu Q, Gao ZJ, Yu X and Wang P: Dietary regulation in health and disease. Signal Transduct Target Ther. 7:2522022. View Article : Google Scholar : PubMed/NCBI

162 

Peixoto P, Cartron PF, Serandour AA and Hervouet E: From 1957 to nowadays: A brief history of epigenetics. Int J Mol Sci. 21:75712020. View Article : Google Scholar : PubMed/NCBI

163 

Sapienza C and Issa JP: Diet, nutrition, and cancer epigenetics. Annu Rev Nutr. 36:665–681. 2016. View Article : Google Scholar : PubMed/NCBI

164 

Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y, Sun Q, Ran S, Li Z, Liu T and Peng L: Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). Int J Mol Med. 54:1042024. View Article : Google Scholar : PubMed/NCBI

165 

Cutfield WS, Hofman PL, Mitchell M and Morison IM: Could epigenetics play a role in the developmental origins of health and disease? Pediatr Res. 61:68R–75R. 2007. View Article : Google Scholar : PubMed/NCBI

166 

Goldberg AD, Allis CD and Bernstein E: Epigenetics: A landscape takes shape. Cell. 128:635–638. 2007. View Article : Google Scholar : PubMed/NCBI

167 

Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K and Haslberger A: Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention. Br J Pharmacol. 167:279–297. 2012. View Article : Google Scholar : PubMed/NCBI

168 

Stover PJ, James WPT, Krook A and Garza C: Emerging concepts on the role of epigenetics in the relationships between nutrition and health. J Intern Med. 284:37–49. 2018. View Article : Google Scholar : PubMed/NCBI

169 

Dehan P, Kustermans G, Guenin S, Horion J, Boniver J and Delvenne P: DNA methylation and cancer diagnosis: new methods and applications. Expert Rev Mol Diagn. 9:651–657. 2009. View Article : Google Scholar : PubMed/NCBI

170 

Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, Hu J, Li J, Guo Z, Cai J, et al: Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output. Cell. 183:76–93.e22. 2020. View Article : Google Scholar : PubMed/NCBI

171 

Lisi V, Senesi G and Balbi C: Converging protective pathways: Exploring the linkage between physical exercise, extracellular vesicles and oxidative stress. Free Radic Biol Med. 208:718–727. 2023. View Article : Google Scholar : PubMed/NCBI

172 

Goodpaster BH and Sparks LM: Metabolic flexibility in health and disease. Cell Metab. 25:1027–1036. 2017. View Article : Google Scholar : PubMed/NCBI

173 

Harris RT and Dudley GA: Exercise alters the distribution of ammonia and lactate in blood. J Appl Physiol (1985). 66:313–317. 1989. View Article : Google Scholar : PubMed/NCBI

174 

King SE and Skinner MK: Epigenetic transgenerational inheritance of obesity susceptibility. Trends Endocrinol Metab. 31:478–494. 2020. View Article : Google Scholar : PubMed/NCBI

175 

Gibson F, Hanly A, Grbic N, Grunberg N, Wu M, Collard M and Alani RM: Epigenetic dysregulation in autoimmune and inflammatory skin diseases. Clin Rev Allergy Immunol. 63:447–471. 2022. View Article : Google Scholar : PubMed/NCBI

176 

Yang Y, Cai J, Yang X, Wang K, Sun K, Yang Z, Zhang L, Yang L, Gu C, Huang X, et al: Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Mol Ther. 30:2342–2353. 2022. View Article : Google Scholar : PubMed/NCBI

177 

Ge T, Gu X, Jia R, Ge S, Chai P, Zhuang A and Fan X: Crosstalk between metabolic reprogramming and epigenetics in cancer: Updates on mechanisms and therapeutic opportunities. Cancer Commun (Lond). 42:1049–1082. 2022. View Article : Google Scholar : PubMed/NCBI

178 

Wątroba M, Dudek I, Skoda M, Stangret A, Rzodkiewicz P and Szukiewicz D: Sirtuins, epigenetics and longevity. Ageing Res Rev. 40:11–19. 2017. View Article : Google Scholar

179 

Avelar RA, Palmer D, Kulaga AY and Fuellen G: Conserved biological processes in partial cellular reprogramming: Relevance to aging and rejuvenation. Ageing Res Rev. 108:1027372025. View Article : Google Scholar : PubMed/NCBI

180 

Wu G, Zhang X and Gao F: The epigenetic landscape of exercise in cardiac health and disease. J Sport Health Sci. 10:648–659. 2021. View Article : Google Scholar

181 

Widmann M, Nieß AM and Munz B: Physical exercise and epigenetic modifications in skeletal muscle. Sports Med. 49:509–523. 2019. View Article : Google Scholar : PubMed/NCBI

182 

Polakovičová M, Musil P, Laczo E, Hamar D and Kyselovič J: Circulating MicroRNAs as Potential Biomarkers of Exercise Response. Int J Mol Sci. 17:15532016. View Article : Google Scholar

183 

Esteller M: Non-coding RNAs in human disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI

184 

Nemeth K, Bayraktar R, Ferracin M and Calin GA: Non-coding RNAs in disease: From mechanisms to therapeutics. Nat Rev Genet. 25:211–232. 2024. View Article : Google Scholar

185 

Xu T, Liu Q, Yao J, Dai Y, Wang H and Xiao J: Circulating microRNAs in response to exercise. Scand J Med Sci Sports. 25:e149–e154. 2015. View Article : Google Scholar : PubMed/NCBI

186 

Statello L, Guo CJ, Chen LL and Huarte M: Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar

187 

Zhao H, Chen X, Hu G, Li C, Guo L, Zhang L, Sun F, Xia Y, Yan W, Cui Z, et al: Small extracellular vesicles from brown adipose tissue mediate exercise cardioprotection. Circ Res. 130:1490–1506. 2022. View Article : Google Scholar : PubMed/NCBI

188 

Dos Santos JAC, Veras ASC, Batista VRG, Tavares MEA, Correia RR, Suggett CB and Teixeira GR: Physical exercise and the functions of microRNAs. Life Sci. 304:1207232022. View Article : Google Scholar : PubMed/NCBI

189 

Wang J, Li L, Zhang Z, Zhang X, Zhu Y, Zhang C and Bi Y: Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance. Cell Metab. 34:1264–1279.e8. 2022. View Article : Google Scholar : PubMed/NCBI

190 

Katayama M, Caria E, Van Simaeys D, Sanz AY, Barrès R, Caidahl K, Wiklander OPB, El Andaloussi S, Berggren PO, Zierath JR and Krook A: Exercise training-induced extracellular miR-136-3p modulates glucose uptake and myogenesis through targeting of NRDC in human skeletal muscle. J Sport Health Sci. 15:1010912025. View Article : Google Scholar : PubMed/NCBI

191 

Ionescu A, Ankol L, Ganapathy Subramaniam A, Altman T, Magen I, Cohen Y, Danino Y, Gradus-Pery T, Niv Y, Bar Avi O, et al: Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models. Nat Neurosci. 28:2201–2216. 2025. View Article : Google Scholar : PubMed/NCBI

192 

Chen M, Li Y, Zhang M, Ge S, Feng T, Chen R, Shen J, Li R, Wang Z, Xie Y, et al: Histone deacetylase inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p. Signal Transduct Target Ther. 9:2562024. View Article : Google Scholar : PubMed/NCBI

193 

Zhao Y, Gao L, Chen J, Wei J, Lin G, Hu K, Zhao W, Wei W, Huang W, Gao L, et al: Remote limb ischemic conditioning alleviates steatohepatitis via extracellular vesicle-mediated muscle-liver crosstalk. Cell Metab. 37:886–902.e7. 2025. View Article : Google Scholar : PubMed/NCBI

194 

Annibalini G, Contarelli S, Lucertini F, Guescini M, Maggio S, Ceccaroli P, Gervasi M, Ferri Marini C, Fardetti F, Grassi E, et al: Muscle and systemic molecular responses to a single flywheel based iso-inertial training session in resistance-trained men. Front Physiol. 10:5542019. View Article : Google Scholar : PubMed/NCBI

195 

Lovett JAC, Durcan PJ and Myburgh KH: Investigation of circulating extracellular vesicle MicroRNA following two consecutive bouts of muscle-damaging exercise. Front Physiol. 9:11492018. View Article : Google Scholar : PubMed/NCBI

196 

Nair VD, Ge Y, Li S, Pincas H, Jain N, Seenarine N, Amper MAS, Goodpaster BH, Walsh MJ, Coen PM and Sealfon SC: Sedentary and trained older men have distinct circulating exosomal microRNA profiles at baseline and in response to acute exercise. Front Physiol. 11:6052020. View Article : Google Scholar : PubMed/NCBI

197 

Fry CS, Kirby TJ, Kosmac K, McCarthy JJ and Peterson CA: Myogenic progenitor cells control extracellular matrix production by fibroblasts during skeletal muscle hypertrophy. Cell Stem Cell. 20:56–69. 2017. View Article : Google Scholar

198 

Ruan S, Du B, Dai C, Wang L, Sun W, Jiang J, Tang Y, Zhang Y, Wang K and Wei Q: Cognitive impairment in patients with middle cerebral artery severe stenosis or occlusion is associated with hemodynamic abnormalities. BMC Neurol. 26:3662026. View Article : Google Scholar : PubMed/NCBI

199 

Perera N, De Blasio MJ and Febbraio MA: Harnessing the therapeutic potential of exercise in extracellular vesicle-based therapy in metabolic disease associated cardiovascular complications. Free Radic Biol Med. 226:230–236. 2025. View Article : Google Scholar

200 

Tiwari S, Kumar V, Randhawa S and Verma SK: Preparation and characterization of extracellular vesicles. Am J Reprod Immunol. 85:e133672021. View Article : Google Scholar

201 

Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, Emanueli C, Gasecka A, Hendrix A, Hill AF, et al: Methodological guidelines to study extracellular vesicles. Circ Res. 120:1632–1648. 2017. View Article : Google Scholar : PubMed/NCBI

202 

Brahmer A, Neuberger EWI, Simon P and Krämer-Albers EM: Considerations for the analysis of small extracellular vesicles in physical exercise. Front Physiol. 11:5761502020. View Article : Google Scholar : PubMed/NCBI

203 

Darragh IAJ, O'Driscoll L and Egan B: Exercise training and circulating small extracellular vesicles: Appraisal of methodological approaches and current knowledge. Front Physiol. 12:7383332021. View Article : Google Scholar : PubMed/NCBI

204 

Karvinen S, Korhonen TM, Sievänen T, Karppinen JE, Juppi HK, Jakoaho V, Kujala UM, Laukkanen JA, Lehti M and Laakkonen EK: Extracellular vesicles and high-density lipoproteins: Exercise and oestrogen-responsive small RNA carriers. J Extracell Vesicles. 12:e123082023. View Article : Google Scholar : PubMed/NCBI

205 

Greening DW, Rai A and Simpson RJ: Extracellular vesicles-An omics view. Proteomics. 24:e24001282024. View Article : Google Scholar : PubMed/NCBI

206 

Wijerathna-Yapa A, Aubert D and Kulasinghe A: Integrating mass spectrometry-based multi-omic signatures of extracellular vesicles: from discovery to clinical translation. Clin Transl Immunology. 15:e700782026. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang X and Zhang B: Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review). Int J Mol Med 58: 220, 2026.
APA
Zhang, X., & Zhang, B. (2026). Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review). International Journal of Molecular Medicine, 58, 220. https://doi.org/10.3892/ijmm.2026.5891
MLA
Zhang, X., Zhang, B."Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review)". International Journal of Molecular Medicine 58.2 (2026): 220.
Chicago
Zhang, X., Zhang, B."Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review)". International Journal of Molecular Medicine 58, no. 2 (2026): 220. https://doi.org/10.3892/ijmm.2026.5891
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X and Zhang B: Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review). Int J Mol Med 58: 220, 2026.
APA
Zhang, X., & Zhang, B. (2026). Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review). International Journal of Molecular Medicine, 58, 220. https://doi.org/10.3892/ijmm.2026.5891
MLA
Zhang, X., Zhang, B."Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review)". International Journal of Molecular Medicine 58.2 (2026): 220.
Chicago
Zhang, X., Zhang, B."Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review)". International Journal of Molecular Medicine 58, no. 2 (2026): 220. https://doi.org/10.3892/ijmm.2026.5891
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team